<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">prmed</journal-id><journal-title-group><journal-title xml:lang="ru">Первичная медико-санитарная помощь</journal-title><trans-title-group xml:lang="en"><trans-title>Primary Health Care (Russian Federation)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-4123</issn><issn pub-type="epub">3034-4565</issn><publisher><publisher-name>LTD "Silicea-Poligraf"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/3034-4123-2025-76</article-id><article-id custom-type="edn" pub-id-type="custom">DBKJIQ</article-id><article-id custom-type="elpub" pub-id-type="custom">prmed-76</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОКАЗАНИЕ МЕДИЦИНСКОЙ ПОМОЩИ РАЗЛИЧНЫМ ГРУППАМ НАСЕЛЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROVIDING MEDICAL CARE TO VARIOUS GROUPS OF THE POPULATION</subject></subj-group></article-categories><title-group><article-title>Иммунопрофилактика. Методические рекомендации (второе издание)</article-title><trans-title-group xml:lang="en"><trans-title>Immunoprophylaxis. Guidelines (second edition)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Оксана Михайловна — д.м.н., профессор, академик РАН, директор ФГБУ "НМИЦ терапии и профилактической медицины" Минздрава России, главный внештатный специалист по терапии и общей врачебной практике Минздрава России, зав. кафедрой терапии и профилактической медицины ФГБОУ ВО "Российский университет медицины" Минздрава России, президент РОПНИЗ</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990, </p><p>ул. Долгоруковская, д. 4. Москва, 127006</p></bio><bio xml:lang="en"><p>Oksana M. Drapkina</p><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990, </p><p>Dolgorukovskaya str., 4, Moscow, 127006</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6446-2744</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брико</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Briko</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Брико Николай Иванович — академик РАН, д.м.н., профессор, заслуженный деятель науки Российской Федерации, зав. кафедрой эпидемиологии и доказательной медицины </p><p>ул. Трубецкая, д. 8, стр. 2, Москва, 119048</p></bio><bio xml:lang="en"><p>Nikolay I. Briko</p><p>Trubetskaya St., 8, bld. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2209-7531</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Намазова-Баранова</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Namazova-Baranova</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Намазова-Баранова Лейла Сеймуровна — академик РАН, д.м.н., профессор, руководитель НИИ педиатрии и охраны здоровья детей НКЦ № 2 ФГБНУ "РНЦХ им. акад. Б. В. Петровского" Минобрнауки России, зав. кафедрой факультетской педиатрии Института материнства и детства ФГАОУ ВО "РНИМУ им. Н. И. Пирогова" Минздрава России (Пироговский университет), главный внештатный детский специалист по профилактической медицине Минздрава России</p><p>Абрикосовский переулок, д. 2, к. 1, Москва,</p><p>ул. Островитянова, д. 1, Москва, 117513</p></bio><bio xml:lang="en"><p>Leyla S. Namazova-Baranova</p><p>2, 1 Abrikosovsky Lane, Moscow,</p><p>Ostrovityanova str., 1, Moscow, 117513</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5999-2150</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авдеев</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Avdeev</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Авдеев Сергей Николаевич — академик РАН, д.м.н., профессор, зав. кафедрой пульмонологии лечебного факультета ФГАОУ ВО "Первый МГМУ им. И. М. Сеченова" Минздрава России (Сеченовский университет), главный внештатный специалист пульмонолог Минздрава России, Вице-президент РОПНИЗ</p><p>ул. Трубецкая, д. 8, стр. 2, Москва, 119048</p></bio><bio xml:lang="en"><p>Sergey N. Avdeev</p><p>Trubetskaya St., 8, bld. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1382-9403</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костинов</surname><given-names>М. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostinov</surname><given-names>M. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Костинов Михаил Петрович — член-корр. РАН, д.м.н., профессор, заслуженный деятель науки Российской Федерации, главный научный сотрудник, зав. лабораторией вакцинопрофилактики и иммунотерапии аллергических заболеваний ФГБНУ "Научно-исследовательский институт вакцин и сывороток им. И. И. Мечникова", зав. кафедрой эпидемиологии и современных технологий вакцинации Института профессионального образования ФГАОУ ВО "Первый МГМУ им. И. М. Сеченова" Минздрава России (Сеченовский университет)</p><p>Малый Казенный переулок, д.5A, Москва, 105064,</p><p>ул. Трубецкая, д. 8, стр. 2, Москва, 119048</p></bio><bio xml:lang="en"><p>Mikhail P. Kostinov</p><p>Trubetskaya St., 8, bld. 2, Moscow, 119048,</p><p> </p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5053-5893</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фельдблюм</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Feldblum</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фельдблюм Ирина Викторовна — д.м.н., профессор, заслуженный врач Российской Федерации, заслуженный деятель науки Российской Федерации, зав. кафедрой эпидемиологии </p><p>ул. Петропавловская, д. 26, Пермь</p></bio><bio xml:lang="en"><p>Irina V. Feldblum</p><p>Petropavlovsk St., 26, Perm</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4146-4787</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полибин</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Polibin</surname><given-names>R. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полибин Роман Владимирович — к.м.н., доцент кафедры эпидемиологии и доказательной медицины, заместитель директора по научной работе Института общественного здоровья им. Ф. Ф. Эрисмана </p><p>ул. Трубецкая, д. 8, стр. 2, Москва, 119048</p></bio><bio xml:lang="en"><p>Roman V. Polibin</p><p>Trubetskaya St., 8, bld. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4467-4707</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алыева</surname><given-names>М. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Alyeva</surname><given-names>M. H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алыева Мая Ходжамурадовна — к.м.н., ассистент кафедры эпидемиологии </p><p>ул. Петропавловская, д. 26, Пермь</p></bio><bio xml:lang="en"><p>Maia H. Alyeva</p><p>Petropavlovsk St., 26, Perm</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреева</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreeva</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андреева Наталья Петровна — к.м.н., доцент кафедры УиЭЗ </p><p>Московский пр-т, д. 15, Чебоксары, 428015, Чувашская Республика</p></bio><bio xml:lang="en"><p>Natalia P. Andreeva</p><p>15 Moskovsky Ave., Cheboksary, 428015</p></bio><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3531-3491</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антонов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Antonov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Антонов Владимир Николаевич — д.м.н., профессор кафедры терапии ИДПО ФГБОУ ВО "Южно-Уральский государственный медицинский университет" Минздрава России, главный пульмонолог Челябинской области</p><p>ул. Воровского, 64, Челябинск, Челябинская область, Уральский федеральный округ, 454141</p></bio><bio xml:lang="en"><p>Vladimir N. Antonov</p><p>64 Vorovskiy St., Chelyabinsk, Chelyabinsk Region, Ural Federal District, 454141</p></bio><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8982-5292</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Demko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Демко Ирина Владимировна — д.м.н., профессор, зав. кафедрой внутренних болезней №2 госпитальной терапии и иммунологии ПО ФГБОУ ВО "Красноярский государственный медицинский университет им. проф. В. Ф. Войно-Ясенецкого" Минздрава России, главный специалист-пульмонолог и аллерголог-иммунолог Сибирского федерального округа</p><p>ул. Партизана Железняка, д. 1, Красноярск, 660022, Красноярский край</p></bio><bio xml:lang="en"><p>Irina V. Demko</p><p>1 Partizan Zheleznyak St., Krasnoyarsk, 660022, Krasnoyarsk Territory</p></bio><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7202-5501</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джумагазиев</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhumagaziev</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джумагазиев Анвар Абдрашитович — д.м.н., профессор, заслуженный врач Российской Федерации, профессор кафедры пропедевтики детских болезней, поликлинической и неотложной педиатрии </p><p>г. Бакинская, д. 121, Астрахань, 414000</p></bio><bio xml:lang="en"><p>Anvar A. Dzhumagaziev</p><p>121 Bakinskaya Street, Astrakhan, 414000</p></bio><xref ref-type="aff" rid="aff-9"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4529-3308</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дроздова</surname><given-names>Л. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Drozdova</surname><given-names>L. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дроздова Любовь Юрьевна — к.м.н., руководитель отдела стратегического планирования и внедрения профилактических технологий, ведущий научный сотрудник ФГБУ "НМИЦ терапии и профилактической медицины" Минздрава России, главный внештатный специалист по медицинской профилактике Минздрава России</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Liubov Yu. Drozdova</p><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8325-5927</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жарова</surname><given-names>М. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Zharova</surname><given-names>M. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жарова Мария Евгеньевна — к.м.н., эксперт Центра организации программ скрининга онкологических заболеваний, врач-гастроэнтеролог </p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Maria E. Zharova</p><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жестков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhestkov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жестков Александр Викторович — д.м.н., профессор, заслуженный деятель науки Российской Федерации, зав. кафедрой клинической медицины Самарский медицинский университет "Реавиз", главный внештатный пульмонолог Приволжского федерального округа</p><p>ул. Чкалова, д. 100, Самара</p></bio><bio xml:lang="en"><p>Aleksandr V. Zhestkov</p><p>100 Chkalova St., Samara</p></bio><xref ref-type="aff" rid="aff-11"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0877-6554</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Игнатова</surname><given-names>Г. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Ignatova</surname><given-names>G. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игнатова Галина Львовна — д.м.н., профессор, зав. кафедрой терапии ИДПО ФГБОУ ВО "Южно-Уральский государственный медицинский университет" Минздрава России, главный специалист-пульмонолог Уральского федерального округа</p><p>ул. Воровского, 64, Челябинск, Челябинская область, Уральский федеральный округ, 454141</p></bio><bio xml:lang="en"><p>Galina L. Ignatova</p><p>64 Vorovskiy St., Chelyabinsk, Chelyabinsk Region, Ural Federal District, 454141</p></bio><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0578-146X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Королева</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Koroleva</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Королева Ирина Станиславовна — д.м.н., советник директора </p><p>ул. Новогиреевская, дом 3А, Москва, 111123</p></bio><bio xml:lang="en"><p>Irina S. Koroleva</p><p>3A Novogireevskaya St., Moscow, 111123</p></bio><xref ref-type="aff" rid="aff-12"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2714-1191</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Королева</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Koroleva</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Королева Мария Александровна — д.м.н., старший научный сотрудник лаборатории эпидемиологии менингококковой инфекции и гнойных бактериальных менингитов </p><p>ул. Новогиреевская, дом 3А, Москва, 111123</p></bio><bio xml:lang="en"><p>Maria A. Koroleva</p><p>3A Novogireevskaya St., Moscow, 111123</p></bio><xref ref-type="aff" rid="aff-12"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коршунов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Korshunov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коршунов Владимир Андреевич — к.м.н., доцент кафедры эпидемиологии и доказательной медицины </p><p>ул. Трубецкая, д. 8, стр. 2, Москва, 119048</p></bio><bio xml:lang="en"><p>Vladimir A. Korshunov</p><p>Trubetskaya St., 8, bld. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0584-2376</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костинова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostinova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Костинова Аристица Михайловна — к.м.н., ассистент кафедры эпидемиологии  и  современных  технологий  вакцинации Института профессионального образования </p><p>ул. Трубецкая, д. 8, стр. 2, Москва, 119048</p></bio><bio xml:lang="en"><p>Aristitsa M. Kostinova</p><p>Trubetskaya St., 8, bld. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5846-851X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркелова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Markelova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маркелова Елена Владимировна — д.м.н., профессор, заведующая кафедрой нормальной и патологической физиологии, </p><p>Проспект Острякова, д. 2, Владивосток, Приморский край, 690002</p></bio><bio xml:lang="en"><p>Elena V. Markelova</p><p>2 Ostryakova Avenue, Vladivostok, Primorsky Krai, 690002</p></bio><xref ref-type="aff" rid="aff-13"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6032-6286</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Межидов</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mezhidov</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Межидов Казбек Султанович — к.м.н., старший научный сотрудник ФГБУ "НМИЦ терапии и профилактической медицины" Минздрава России, главный внештатный специалист педиатр и по профилактической медицине Минздрава России в СКФО</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Kazbek S. Mezhidov</p><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0533-0909</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полищук</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Polishchuk</surname><given-names>V. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полищук Валентина Борисовна — к.м.н., ведущий научный сотрудник лаборатории вакцинопрофилактики и иммунотерапии аллергических заболеваний </p><p>Малый Казенный переулок, д.5A, Москва, 105064</p></bio><bio xml:lang="en"><p>Valentina B. Polishchuk</p><p>5A Maly Kazenniy Lane, Moscow, 105064</p></bio><xref ref-type="aff" rid="aff-14"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8452-5776</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Протасов</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Protasov</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Протасов Андрей Дмитриевич — д.м.н., доцент, зав. кафедрой фундаментальных дисциплин Международного института, заместитель директора Международного института </p><p>ул. Чапаевская, д. 89, Самара, 443099</p></bio><bio xml:lang="en"><p>Andrey D. Protasov</p><p>89 Chapaevskaya St., Samara, 443099</p></bio><xref ref-type="aff" rid="aff-15"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0442-783X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рудакова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rudakova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рудакова Алла Всеволодовна — д.фарм.н., профессор, старший научный сотрудник отдела вакцинопрофилактики и поствакцинальной патологии ФГБУ "Федеральный научно-клинический центр инфекционных болезней Федерального медико-биологического агентства России", профессор кафедры управления и экономики фармации ФГБОУ ВО "Санкт-Петербургский государственный химико-фармацевтический университет" Минздрава России</p><p>ул. Профессора Попова, д. 9, Санкт-Петербург, 197022, </p><p>ул. Профессора Попова, д. 14, Санкт-Петербург</p></bio><bio xml:lang="en"><p>Alla V. Rudakova</p><p>Professora Popova str., 9, St. Petersburg, 197022,</p><p>Professora Popova str., 14, Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-16"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7759-2003</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рыжов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryzhov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рыжов Алексей Анатольевич  — к.м.н., ведущий научный сотрудник лаборатории вакцинопрофилактики и иммунотерапии аллергических заболеваний  </p><p>Малый Казенный переулок, д.5A, Москва, 105064</p></bio><bio xml:lang="en"><p>Alexey A. Ryzhov</p><p>5A Maly Kazenniy Lane, Moscow, 105064</p></bio><xref ref-type="aff" rid="aff-14"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3217-2029</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сависько</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savisko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сависько Анна Алексеевна — к.м.н., доцент кафедры поликлинической и неотложной педиатрии </p><p>пер. Нахичеванский, д. 29, Ростов-на-Дону, Ростовская область, 344022</p></bio><bio xml:lang="en"><p>Anna A. Savisko</p><p>Nakhichevansky per., 29, Rostov-on-Don, Rostov region, 344022</p></bio><xref ref-type="aff" rid="aff-17"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6208-3038</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смирнова Марина Игоревна — к.м.н., ведущий научный сотрудник отдела первичной профилактики хронических неинфекционных заболеваний в системе здравоохранения </p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Marina I. Smirnova</p><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соловьева</surname><given-names>И. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Solovyova</surname><given-names>I. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Соловьева Ирина Леонидовна — д.м.н., доцент, профессор, зав. кафедрой педиатрии</p><p>ул. Льва Толстого, д. 42, Ульяновск, 432017</p></bio><bio xml:lang="en"><p>Irina L. Solovyova</p><p>42 Lva Tolstogo str., Ulyanovsk, 432017</p></bio><xref ref-type="aff" rid="aff-18"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0060-6251</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Субботина</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Subbotina</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Субботина Ксения Андреевна — к.м.н., доцент кафедры эпидемиологии </p><p>ул. Петропавловская, д. 26, Пермь</p></bio><bio xml:lang="en"><p>Ksenya A. Subbotina</p><p>Petropavlovsk St., 26, Perm</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-9617-9859</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарасова Алла Анатольевна — д.м.н., профессор кафедры факультетской и поликлинической педиатрии </p><p>г. пл. Минина и Пожарского.д.10/1, Нижний Новгород, 603005</p></bio><bio xml:lang="en"><p>Alla A. Tarasova</p><p>10/1 Minin and Pozharsky Squares, Nizhny Novgorod, 603005</p></bio><xref ref-type="aff" rid="aff-19"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0797-5612</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федосеенко</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedoseenko</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Федосеенко Марина Владиславовна — к.м.н., зав. отделом разработки научных подходов к иммунизации пациентов с отклонениями в состоянии здоровья и хроническими болезнями, ведущий научный сотрудник НИИ педиатрии и охраны здоровья детей НКЦ№2 ФГБНУ "РНЦХ им. акад. Б. В. Петровского" Минобрнауки России, доцент кафедры факультетской педиатрии Института материнства и детства ФГАОУ ВО "РНИМУ им. Н. И. Пирогова" Минздрава России (Пироговский университет)</p><p>Абрикосовский переулок, д. 2, к. 1, Москва,</p><p>ул. Островитянова, д. 1, Москва, 117513</p></bio><bio xml:lang="en"><p>Marina V. Fedoseenko</p><p>2, 1 Abrikosovsky Lane, Moscow,</p><p>Ostrovityanova str., 1, Moscow, 117513</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6226-2183</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харсеева</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kharseeva</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Харсеева Галина Георгиевна — д.м.н., профессор, зав. кафедрой микробиологии и вирусологии №2 </p><p>пер. Нахичеванский, д. 29, Ростов-на-Дону, Ростовская область, 344022</p></bio><bio xml:lang="en"><p>Galina G. Kharseeva</p><p>Nakhichevansky per., 29, Rostov-on-Don, Rostov region, 344022</p></bio><xref ref-type="aff" rid="aff-17"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7823-9287</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цапкова</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsapkova</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цапкова Наталья Николаевна — к.м.н., доцент кафедры эпидемиологии и доказательной медицины </p><p>ул. Трубецкая, д. 8, стр. 2, Москва, 119048</p></bio><bio xml:lang="en"><p>Natalia N. Tsapkova</p><p>Trubetskaya St., 8, bld. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6589-3354</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черданцев</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Cherdantsev</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Черданцев Александр Петрович — д.м.н., доцент, профессор кафедры педиатрии ФГБОУ ВО "Ульяновский государственный университет" Минобрнауки России, главный внештатный специалист аллерголог-иммунолог Минздрава Ульяновской области</p><p>ул. Льва Толстого, д. 42, Ульяновск, 432017</p></bio><bio xml:lang="en"><p>Aleksandr P. Cherdantsev</p><p>42 Lva Tolstogo str., Ulyanovsk, 432017</p></bio><xref ref-type="aff" rid="aff-18"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8984-9056</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шепель</surname><given-names>Р. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Shepel</surname><given-names>R. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шепель Руслан Николаевич — к.м.н., зам. директора по перспективному развитию медицинской деятельности ФГБУ "НМИЦ терапии и профилактической медицины" Минздрава России, главный внештатный специалист по терапии Минздрава России в Центральном федеральном округе, доцент кафедры терапии и профилактической медицины ФГБОУ ВО "Российский университет медицины" Минздрава России</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990,</p><p>ул. Долгоруковская, д. 4. Москва, 127006</p></bio><bio xml:lang="en"><p>Ruslan N. Shepel</p><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990, </p><p>Dolgorukovskaya str., 4, Moscow, 127006</p></bio><email xlink:type="simple">r.n.shepel@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шмитько</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Shmitko</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шмитько Анна Дмитриевна — к.м.н., старший научный сотрудник лаборатории вакцинопрофилактики и иммунотерапии аллергических заболеваний </p><p>Малый Казенный переулок, д.5A, Москва, 105064</p></bio><bio xml:lang="en"><p>Anna D. Shmitko</p><p>5A Maly Kazenniy Lane, Moscow, 105064</p></bio><xref ref-type="aff" rid="aff-14"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России;&#13;
ФГБОУ ВО "Российский университет медицины" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation;&#13;
Russian University of Medicine" of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО "Первый МГМУ им. И. М. Сеченова" Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ "Российский научный центр хирургии им. акад. Б. В. Петровского" Минобрнауки России;&#13;
ФГАОУ ВО "РНИМУ им. Н. И. Пирогова" Минздрава России (Пироговский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>B. V. Petrovsky Russian Scientific Center of Surgery, Ministry of Education and Science of the Russian Federation;&#13;
Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation (Pirogov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБНУ "Научно-исследовательский институт вакцин и сывороток им. И. И. Мечникова";&#13;
ФГАОУ ВО "Первый МГМУ им. И. М. Сеченова" Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation;</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГБОУ ВО "Пермский государственный медицинский университет им. акад. Е. А. Вагнера" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E. A. Wagner Perm State Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>ФГБОУ ВО "Чувашский государственный университет им. И. Н. Ульянова" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I. N. Ulyanov Chuvash State University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>ФГБОУ ВО "Южно-Уральский государственный медицинский университет" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural State Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>ФГБОУ ВО "Красноярский государственный медицинский университет им. проф. В. Ф. Войно-Ясенецкого" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V. F. Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-9"><aff xml:lang="ru"><institution>ФГБОУ ВО "Астраханский государственный медицинский университет" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Astrakhan State Medical University of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-10"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-11"><aff xml:lang="ru"><institution>Самарский медицинский университет "Реавиз"</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara Medical University "Reaviz"</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-12"><aff xml:lang="ru"><institution>ФБУН "Центральный научно-исследовательский институт эпидемиологии" Роспотребнадзора</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Scientific Research Institute of Epidemiology of Rospotrebnadzor</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-13"><aff xml:lang="ru"><institution>ФГБОУ ВО "Тихоокеанский государственный медицинский университет" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pacific State Medical University of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-14"><aff xml:lang="ru"><institution>ФГБНУ "Научно-исследовательский институт вакцин и сывороток им. И. И. Мечникова"</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I. I. Mechnikov Scientific Research Institute of Vaccines and Serums</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-15"><aff xml:lang="ru"><institution>ФГБОУ ВО "Самарский государственный медицинский университет" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara State Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-16"><aff xml:lang="ru"><institution>ФГБУ "Федеральный научно-клинический центр инфекционных болезней Федерального медико-биологического агентства России";&#13;
ФГБОУ ВО "Санкт-Петербургский государственный химико-фармацевтический университет" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific and Clinical Center for Infectious Diseases of the Federal Medical and Biological Agency of Russia;&#13;
Saint Petersburg State University of Chemistry and Pharmacy, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-17"><aff xml:lang="ru"><institution>ФГБОУ ВО "Ростовский государственный медицинский университет" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>RostSMU of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-18"><aff xml:lang="ru"><institution>ФГБОУ ВО "Ульяновский государственный университет" Минобрнауки России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ulyanovsk State University, Ministry of Education and Science of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-19"><aff xml:lang="ru"><institution>ФГБОУ ВО "Приволжский исследовательский медицинский университет" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volga Region Research Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>18</day><month>10</month><year>2025</year></pub-date><volume>2</volume><issue>3</issue><fpage>135</fpage><lpage>262</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Драпкина О.М., Брико Н.И., Намазова-Баранова Л.С., Авдеев С.Н., Костинов М.П., Фельдблюм И.В., Полибин Р.В., Алыева М.Х., Андреева Н.П., Антонов В.Н., Демко И.В., Джумагазиев А.А., Дроздова Л.Ю., Жарова М.Е., Жестков А.В., Игнатова Г.Л., Королева И.С., Королева М.А., Коршунов В.А., Костинова А.М., Маркелова Е.В., Межидов К.С., Полищук В.Б., Протасов А.Д., Рудакова А.В., Рыжов А.А., Сависько А.А., Смирнова М.И., Соловьева И.Л., Субботина К.А., Тарасова А.А., Федосеенко М.В., Харсеева Г.Г., Цапкова Н.Н., Черданцев А.П., Шепель Р.Н., Шмитько А.Д., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Драпкина О.М., Брико Н.И., Намазова-Баранова Л.С., Авдеев С.Н., Костинов М.П., Фельдблюм И.В., Полибин Р.В., Алыева М.Х., Андреева Н.П., Антонов В.Н., Демко И.В., Джумагазиев А.А., Дроздова Л.Ю., Жарова М.Е., Жестков А.В., Игнатова Г.Л., Королева И.С., Королева М.А., Коршунов В.А., Костинова А.М., Маркелова Е.В., Межидов К.С., Полищук В.Б., Протасов А.Д., Рудакова А.В., Рыжов А.А., Сависько А.А., Смирнова М.И., Соловьева И.Л., Субботина К.А., Тарасова А.А., Федосеенко М.В., Харсеева Г.Г., Цапкова Н.Н., Черданцев А.П., Шепель Р.Н., Шмитько А.Д.</copyright-holder><copyright-holder xml:lang="en">Drapkina O.M., Briko N.I., Namazova-Baranova L.S., Avdeev S.N., Kostinov M.P., Feldblum I.V., Polibin R.V., Alyeva M.H., Andreeva N.P., Antonov V.N., Demko I.V., Dzhumagaziev A.A., Drozdova L.Y., Zharova M.E., Zhestkov A.V., Ignatova G.L., Koroleva I.S., Koroleva M.A., Korshunov V.A., Kostinova A.M., Markelova E.V., Mezhidov K.S., Polishchuk V.B., Protasov A.D., Rudakova A.V., Ryzhov A.A., Savisko A.A., Smirnova M.I., Solovyova I.L., Subbotina K.A., Tarasova A.A., Fedoseenko M.V., Kharseeva G.G., Tsapkova N.N., Cherdantsev A.P., Shepel R.N., Shmitko A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://prmed.elpub.ru/jour/article/view/76">https://prmed.elpub.ru/jour/article/view/76</self-uri><abstract><p>Иммунопрофилактика является одним из наиболее эффективных инструментов снижения заболеваемости и смертности от инфекционных заболеваний. В условиях глобальных эпидемиологических вызовов и роста мобильности населения вопросы организации иммунизации, правильного отбора пациентов, безопасности и эффективности вакцинации приобретают особую значимость.</p><p>Документ систематизирует современные подходы к организации и проведению вакцинации взрослых. Включены разделы о принципах планирования и технике вакцинации, противопоказаниях и "ложных противопоказаниях", особенностях вакцинации против конкретных инфекций (грипп, пневмококковая инфекция, гепатиты, дифтерия, столбняк, полиомиелит, корь, краснуха и др.), а также о вакцинопрофилактике у беременных и военнослужащих. Особое внимание уделено регистрации и лечению поствакцинальных реакций и осложнений, и экономической эффективности вакцинации.</p><p>Методические рекомендации предназначены для врачей-терапевтов, инфекционистов, эпидемиологов, педиатров, а также специалистов по организации здравоохранения.</p></abstract><trans-abstract xml:lang="en"><p>Immunoprophylaxis is one of the most effective tools for reducing morbidity and mortality from infectious diseases. In the context of global epidemiological challenges and increased population mobility, the issues of managing immunization, proper patient selection, safety and effectiveness of vaccination are of particular importance.</p><p>The document systematizes modern approaches to organizing and conducting vaccination of adults. It includes sections on planning and vaccination techniques, contraindications and "false contraindications", features of vaccination against specific infections (influenza, pneumococcal infection, hepatitis, diphtheria, tetanus, poliomyelitis, measles, rubella, etc.), as well as vaccination in pregnant women and military personnel. Particular attention is paid to the registration and treatment of post-vaccination reactions and complications, and the costeffectiveness of vaccination.</p><p>The guidelines are intended for general practitioners, infectious disease specialists, epidemiologists, pediatricians, and public health specialists.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>иммунопрофилактика</kwd><kwd>вакцинопрофилактика</kwd><kwd>иммунизация взрослых</kwd><kwd>национальный календарь прививок</kwd><kwd>первичная медико-санитарная помощь</kwd><kwd>противопоказания к вакцинации</kwd><kwd>поствакцинальные реакции</kwd><kwd>организация вакцинации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>immunoprophylaxis</kwd><kwd>vaccination prophylaxis</kwd><kwd>adult immunization</kwd><kwd>national vaccination schedule</kwd><kwd>primary health care</kwd><kwd>contraindications to vaccination</kwd><kwd>post-vaccination reactions</kwd><kwd>vaccination management</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Зверева В.В., Семенова Б.Ф., Хаитова Р.М. Вакцины и вакцинация: национальное руководство. Москва: ГЭОТАР-Медиа, 2011. 880 с.</mixed-citation><mixed-citation xml:lang="en">Zvereva VV, Semenova BF, Khaitova RM. Vaccines and vaccination: national guidelines. Moscow: GEOTAR-Media, 2011. 880 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Зверева В.В., Хаитова Р.М. Вакцины и вакцинация. Национальное руководство. Краткое издание. 2014. 640 с.</mixed-citation><mixed-citation xml:lang="en">Zvereva BB, Khaitova RM. Vaccines and vaccinations. National guideline. Short edition. 2014. 640 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Тарасова А.А., Лукушкина Е.Ф., Костинов М.П. и др. Вакцинопрофилактика. Нижний Новгород: "Издательский салон" ИП Гладкова О.В., 2016. 103 с.</mixed-citation><mixed-citation xml:lang="en">Tarasova AA, Lukushkina EF, Kostinov MP, et al. Vaccination prevention. Nizhny Novgorod: Publishing Salon of IP Gladkova O.V., 2016. 103 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Чучалин А.Г. Руководство по клинической иммунологии в респираторной медицине. 1-е изд. Т. 2016. Москва: ООО АТМО. 126 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Chuchalin AG. Guidelines for clinical immunology in respiratory medicine. 1st ed. Vol. 2016. Moscow: ATMO LLC. 126 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Чучалин А.Г., Яснецова В.В. Федеральное руководство по использованию лекарственных средств (формулярная система, справочное издание). Москва: ООО Видокс, 2016. 745-768 с.</mixed-citation><mixed-citation xml:lang="en">Chuchalin AG, Yasnetsova VV. Federal Guidelines on the use of medicines (formulary system, reference edition). Moscow: Vidox LLC, 2016. 745-768 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Таточенко В.К., Озерецковского Н.А. Иммунопрофилактика. 14-е изд. Москва: Педиатръ, 2020. 384 с.</mixed-citation><mixed-citation xml:lang="en">Tatochenko VK, Ozeretskovsky ON. Immunoprophylaxis. 14th ed. Moscow: Pediatrician, 2020. 384 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Намазова-Баранова Л.С., Брико Н.И., Фельдблюм И.В. Вакцины и иммунопрофилактика в современном мире. Руководство для врачей. Педиатр Ъ. Москва, 2021. 648 с.</mixed-citation><mixed-citation xml:lang="en">Namazova-Baranova LS, Briko NI, Feldblum IV. Vaccines and immunoprophylaxis in the modern world. A guide for doctors. Pediatrician. Moscow, 2021. 648 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Брико Н.И., Фельдблюм И.В. Современная концепция развития вакцинопрофилактики в России. Эпидемиология и вакцинопрофилактика. 2019;18(5):4-13.</mixed-citation><mixed-citation xml:lang="en">Briko NI, Feldblum YV. The modern concept of vaccine prevention development in Russia. Epidemiology and vaccine prevention. 2019;18(5):4-13. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Фельдблюм И.В., Зуева Л.П., Асланов Б.И. Вакцинопрофилактика у детей и взрослых: Руководство для врачей. ГЭОТАР-Медиа. Санкт-Петербург, 2023. 288 с.</mixed-citation><mixed-citation xml:lang="en">Feldblum IV, Zueva LP, Aslanov BI. Vaccine prevention in children and adults: A guide for doctors. GEOTAR-Media. St.Petersburg, 2023. 288 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Чучалин А.Г., Биличенко Т.И., Осипова Г.Л. Вакцинопрофилактика болезней органов дыхания в рамках первичной медико-санитарной помощи населению. Клинические рекомендации. Пульмонология. 2015;25(2):1-19.</mixed-citation><mixed-citation xml:lang="en">Chuchalin AG, Bilichenko TI, Osipova GL. Vaccinoprophylaxis of respiratory diseases in the framework of primary health care for the population. Clinical recommendations. Pulmonology. 2015;25(2):1-19. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Зверева В.В. Вакцинация против гепатита В, гриппа и краснухи взрослых пациентов с хроническими заболеваниями. Руководство. Москва: МДВ; 196 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Zvereva BB. Vaccination against hepatitis B, influenza and rubella in adult patients with chronic diseases. Guide. Moscow: MDV; 196 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Протасов А.Д., Жестков А.В., Лаврентьева Н.Е. и др. Эффект комплексной вакцинации против пневмококковой, гемофильной типа b инфекций и гриппа у пациентов с хронической обструктивной болезнью легких. Журнал микробиологии, эпидемиологии и иммунобиологии. 2011;88(4):80-4.</mixed-citation><mixed-citation xml:lang="en">Protasov AD, Zhestkov AB, Lavrentieva NE, et al. The effect of complex vaccination against pneumococcal, hemophilic type b infections and influenza in patients with chronic obstructive pulmonary disease. Journal of Microbiology, Epidemiology and Immunobiology. 2011;88(4):80-4. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. Вакцинация взрослых с бронхолегочной патологией. Руководство для врачей. Москва: Арт студия Созвездие, 2013. 112 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP. Vaccination of adults with bronchopulmonary pathology. A guide for doctors. Moscow: Art Studio Constellation, 2013. 112 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев А.П., Кусельман А.И., Синицына М.Н. и др. Изучение клинической безопасности вакцинации против гриппа у беременных. Медицинский альманах. 2011;17(4):120-2.</mixed-citation><mixed-citation xml:lang="en">Cherdantsev AP, Kuselman AI, Sinitsyna MN, et al. To study the clinical safety of influenza vaccination in pregnant women. Medical almanac. 2011;17(4):120-2. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Бухтияеров И.В., Брико Н.И., Рослая Н.А. и др. Вакцинопрофилактика работающего населения Руководство для врачей. Москва: Медицинское информационное агентство, 2019. 189 с.</mixed-citation><mixed-citation xml:lang="en">Bukhtiyarov IV, Briko NI, Roslaya NA, et al. Vaccination of the working population is a guide for doctors. Moscow: Medical Information Agency, 2019. 189 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Зверев В.В., Костинов М.П., Черданцев А.П. Вакцинация беременных против гриппа: Федеральные клинические рекомендации. Москва; 42 с.</mixed-citation><mixed-citation xml:lang="en">Zverev BB, Kostinov MP, Cherdantsev AP. Vaccination of pregnant women against influenza: Federal clinical guidelines. Moscow; 42 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. Вакцинация детей с нарушенным состоянием здоровья. Практическое руководство для врачей. 4-е изд. Москва: Медицина для всех, 2013. 432 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP. Vaccination of children with impaired health. A practical guide for doctors. 4th ed. Moscow: Medicine for All, 2013. 432 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Брико Н.И., Симонова Е.Г., Костинов М.П. и др. Иммунопрофилактика пневмококковых инфекций. Нижний Новгород: Ремедиум Приволжье, 2013. 278 с.</mixed-citation><mixed-citation xml:lang="en">Briko NI, Simonova EG, Kostinov MP, et al. Immunoprophylaxis of pneumococcal infections. Nizhny Novgorod: Remedium Privolzhye, 2013. 278 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Тарасова А.А. Вакцинопрофилактика пневмококковой инфекции и гриппа при аутоиммунных заболеваниях: руководство для врачей. Москва: Издательство МДВ, 2009. 252 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Tarasova AA. Vaccination of pneumococcal infection and influenza in autoimmune diseases: a guide for doctors. Moscow: MDV Publishing House, 2009. 252 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. Расширение комплекса лечебно-профилактических мероприятий при бронхиальной астме у детей с применением вакцин "ПНЕВМО 23" и "АктХИБ". Пособие для врачей. Москва: Медицина для всех, 2004. 36 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP. Expansion of the complex of therapeutic and preventive measures for bronchial asthma in children with the use of vaccines "PNEUMO 23" and "AktHIB". A manual for doctors. Moscow: Medicine for All, 2004. 36 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Гаращенко Т.И., Костинов М.П., Ильенко Л.И. и др. Профилактическое и терапевтическое использование гемофильной и пневмококковой вакцин у часто и длительно болеющих детей с рецидивирующими средними отитами. Вопросы современной педиатрии. 2006;5(5):24-8.</mixed-citation><mixed-citation xml:lang="en">Garashchenko TI, Kostinov MP, Ilyenko LI, et al. Preventive and therapeutic use of hemophilic and pneumococcal vaccines in frequently and long-term ill children with recurrent otitis media. Issues of modern pediatrics. 2006;5(5):24-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Маркелова Е.В., Гущина Я.С., Костинов М.П., Журавлева Н.В. Клиникоиммунологический эффект вакцинации "ПНЕВМО 23" детей с атопической бронхиальной астмой. Журнал микробиологии, эпидемиологии и иммунобиологии. 2005;(2):83-5.</mixed-citation><mixed-citation xml:lang="en">Markelova E.V., Guschina Ya.S., Kostinov M.P., Zhuravleva N.V. Clinical and immunological effect of vaccination with "PNEUMONIA 23" in children with atopic bronchial asthma. Journal of Microbiology, Epidemiology and Immunobiology. 2005;(2):83-5. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Озерецковский Н.А. Клинико-иммунологическая эффективность иммунобиологических препаратов. Справочник. Москва: Миклош, 2004. 256 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov M.P., Ozeretskovsky N.A. Clinical and immunological efficacy of immunobiological drugs. Guide. Moscow: Miklos, 2004. 256 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Черданцев А.П., Сависько А.А. и др. Истинные и ложные реакции на введение вакцины против гриппа у беременных. Вопросы гинекологии, акушерства и перинатологии. 2011;10(6):44-8.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Cherdantsev AP, Savisko AA, et al. True and false reactions to the introduction of the flu vaccine in pregnant women. Issues of gynecology, obstetrics and perinatology. 2011;10(6):44-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Магаршак О.О., Костинов М.П. Проблемы вакцинации детей с аллергическими заболеваниями. Лечащий врач. 2008;(9):44-8.</mixed-citation><mixed-citation xml:lang="en">Magarshak OO, Kostinov MP. Problems of vaccination of children with allergic diseases. The attending physician. 2008;(9):44-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев А.П., Костинов, М.П., Кусельман А.И. Вакцинопрофилактика гриппа у беременных. Руководство для врачей. Москва: Группа МДВ, 2014. 112 с.</mixed-citation><mixed-citation xml:lang="en">Cherdantsev AP, Kostinov, MP, Kuselman AI. Vaccination of influenza in pregnant women. A guide for doctors. Moscow: MDV Group, 2014. 112 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев А.П., Костинов М.П., Кусельман А.И. Вакцинация беременных против гриппа и других инфекционных заболеваний. Руководство для врачей. 3-е изд. Москва: Группа МДВ, 2018. 143 с.</mixed-citation><mixed-citation xml:lang="en">Cherdantsev AP, Kostinov MP, Kuselman AI. Vaccination of pregnant women against influenza and other infectious diseases. A guide for doctors. 3rd ed. Moscow: MDV Group, 2018. 143 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Рудакова А.В., Брико Н.И., Лобзин Ю.В. и др. Эффективность затрат на вакцинацию против пневмококковой инфекции взрослых из групп риска в рамках федеральных и региональных программ. Журнал инфектологии. 2019;11(4):6-18.</mixed-citation><mixed-citation xml:lang="en">Rudakova AV, Briko NI, Lobzin YuV, et al. Cost-effectiveness of vaccination against pneumococcal infection in adults at risk within the framework of federal and regional programs. Journal of Infectology. 2019;11(4):6-18. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Committee on Infectious Diseases, O’Leary ST, Campbell JD, Ardura MI, et al. Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Policy Statement. Pediatrics. 2024;154(4):e2024068507.</mixed-citation><mixed-citation xml:lang="en">Committee on Infectious Diseases, O’Leary ST, Campbell JD, Ardura MI, et al. Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Policy Statement. Pediatrics. 2024;154(4):e2024068507.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Wall DJ, Patel MM, Chung JR, et al. Antibody Response and Protection After Receipt of Inactivated Influenza Vaccine: A Systematic Review. Pediatrics. 2021;147(6): e2020019901.</mixed-citation><mixed-citation xml:lang="en">Wall DJ, Patel MM, Chung JR, et al. Antibody Response and Protection After Receipt of Inactivated Influenza Vaccine: A Systematic Review. Pediatrics. 2021;147(6): e2020019901.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Y, Yang W, Li X, et al. Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3-8 Years. Vaccines. 2023; 11(10):1586.</mixed-citation><mixed-citation xml:lang="en">Shi Y, Yang W, Li X, et al. Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3-8 Years. Vaccines. 2023; 11(10):1586.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Cordero E, Roca-Oporto C, Bulnes-Ramos A, et al. Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial. Clinical Infectious Diseases. 2017;64(7):829-38.</mixed-citation><mixed-citation xml:lang="en">Cordero E, Roca-Oporto C, Bulnes-Ramos A, et al. Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial. Clinical Infectious Diseases. 2017;64(7):829-38.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Российское респираторное общество. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких. Пульмонология. 2014;3:15-54.</mixed-citation><mixed-citation xml:lang="en">Chuchalin AG, Avdeev SN, Aisanov ZR, et al. Russian Respiratory Society. Federal clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonology. 2014;3:15-54. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2019. 139 p.</mixed-citation><mixed-citation xml:lang="en">Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2019. 139 p.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ткачева О.Н., Котовская Ю.В., Костинов М.П. и др. Вакцинация лиц пожилого и старческого возраста: Методические рекомендации. Т.Версия 1. М., 2020. 48 с.</mixed-citation><mixed-citation xml:lang="en">Tkacheva ON, Kotovskaya SE, Kostinov MP, et al. Vaccination of the elderly and senile: Methodological recommendations. Vol. Version 1. M., 2020. 48 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Сон И.М. Медико-демографические показатели Российской Федерации в 2018 году. Статистический сборник. М., 2019. 253 с.</mixed-citation><mixed-citation xml:lang="en">Son IM. Medical and demographic indicators of the Russian Federation in 2018. Statistical collection. Moscow, 2019. 253 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Коршунов В.А., Брико Н.И., Полибин Р.В., и др. Охват вакцинацией против пневмококковой инфекции взрослых групп риска в Российской Федерации. Эпидемиология и вакцинопрофилактика. 2024;23(6):13-23.</mixed-citation><mixed-citation xml:lang="en">Korshunov VA, Briko NI, Polybin RV, et al. Vaccination coverage against pneumococcal infection in adult risk groups in the Russian Federation. Epidemiology and vaccine prevention. 2024;23(6):13-23. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices — United States, 2013-2014. MMWR Recomm Rep. 2013;45(62):906.</mixed-citation><mixed-citation xml:lang="en">Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices — United States, 2013-2014. MMWR Recomm Rep. 2013;45(62):906.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2008;(1):CD000422. doi:10.1002/14651858.CD000422.pub2. Update in: Cochrane Database Syst Rev. 2013;(1): CD000422. doi:10.1002/14651858.CD000422.pub3.</mixed-citation><mixed-citation xml:lang="en">Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2008;(1):CD000422. doi:10.1002/14651858.CD000422.pub2. Update in: Cochrane Database Syst Rev. 2013;(1): CD000422. doi:10.1002/14651858.CD000422.pub3.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Loddenkemper R, Gibson GJ, Sibille Y.The burden of lung disease in Europe: data from the first European White Book. Breathe. 2004;1(1):7-9.</mixed-citation><mixed-citation xml:lang="en">Loddenkemper R, Gibson GJ, Sibille Y.The burden of lung disease in Europe: data from the first European White Book. Breathe. 2004;1(1):7-9.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов А.А., Намазова-Баранова Л.С., Брико Н.И. и др. Вакцинопрофилактика пневмококковой инфекции у детей и взрослых Методические рекомендации. М.: Общество с ограниченной ответственностью Издательство "Педиатръ", 2023. 92 с. ISBN: 978-5-6046793-7-1. EDN: WMDKYB.</mixed-citation><mixed-citation xml:lang="en">Baranov AA, Namazova-Baranova LS, Briko NI, et al. Vaccinoprophylaxis of pneumococcal infection in children and adults Methodological recommendations. Moscow: Limited Liability Company Publishing House "Pediatrician", 2023. 92 p. (In Russ.) EDN: WMDKYB.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеев С.Н., Алыева М.Х., Баранов А.А. и др. Вакцинопрофилактика пневмококковой инфекции у детей и взрослых. Методические рекомендации. Профилактическая медицина. 2023;26(9):3-23.</mixed-citation><mixed-citation xml:lang="en">Avdeev SN, Alyeva MH, Baranov AA, et al. Vaccinoprophylaxis of pneumococcal infection in children and adults. Methodological recommendations. Preventive medicine. 2023;26(9):3-23. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Брико Н.И., Коршунов В.А., Лобзин Ю.В. и др. Десятилетний опыт применения 13-валентной конъюгированной полисахаридной пневмококковой вакцины в Российской Федерации. Эпидемиология и вакцинопрофилактика. 2023;(4):106-39.</mixed-citation><mixed-citation xml:lang="en">Briko NI, Korshunov VA, Lobzin YuV, et al. Ten years of experience in the use of 13-valent conjugated polysaccharide pneumococcal vaccine in the Russian Federation. Epidemiology and vaccine prevention. 2023;(4):106-39. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Cannon K, Elder C, Young M, et al. A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination. Vaccine. 2021;39(51):7494-502.</mixed-citation><mixed-citation xml:lang="en">Cannon K, Elder C, Young M, et al. A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination. Vaccine. 2021;39(51):7494-502.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Klein NP, Peyrani P, Yacisin K, et al. A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Vaccine. 2021;39(38):5428-35.</mixed-citation><mixed-citation xml:lang="en">Klein NP, Peyrani P, Yacisin K, et al. A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Vaccine. 2021;39(38):5428-35.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Rockwell PG. ACIP approves 2023 child/adolescent and adult immunization schedules. American Family Physician. 2023;107(3):319-22.</mixed-citation><mixed-citation xml:lang="en">Rockwell PG. ACIP approves 2023 child/adolescent and adult immunization schedules. American Family Physician. 2023;107(3):319-22.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Bass AR, Chakravarty E, Akl EA, et al. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023;75(3):449-64.</mixed-citation><mixed-citation xml:lang="en">Bass AR, Chakravarty E, Akl EA, et al. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023;75(3):449-64.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Kobayashi M, Leidner AJ, Gierke R, et al. Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morb Mortal Wkly Rep. 2025;74(1):1-8.</mixed-citation><mixed-citation xml:lang="en">Kobayashi M, Leidner AJ, Gierke R, et al. Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morb Mortal Wkly Rep. 2025;74(1):1-8.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Horberg M, Thompson M, Agwu A, et al. Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2024:ciae479. doi:10.1093/cid/ciae479. Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Horberg M, Thompson M, Agwu A, et al. Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2024:ciae479. doi:10.1093/cid/ciae479. Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Kamboj M, Bohlke K, Baptiste DM, et al. Vaccination of Adults With Cancer: ASCO Guideline. J Clin Oncol. 2024;42(14):1699-721.</mixed-citation><mixed-citation xml:lang="en">Kamboj M, Bohlke K, Baptiste DM, et al. Vaccination of Adults With Cancer: ASCO Guideline. J Clin Oncol. 2024;42(14):1699-721.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатова Г.Л., Антонов В.Н., Блинова Е.В. Анализ эффективности совместной или последовательной вакцинации пневмококковыми и гриппозными вакцинами у пациентов с хронической обструктивной болезнью легких. Терапевтический архив. 2019;91(8):12-7.</mixed-citation><mixed-citation xml:lang="en">Ignatova GL, Antonov VN, Blinova EV. Analysis of the effectiveness of combined or sequential vaccination with pneumococcal and influenza vaccines in patients with chronic obstructive pulmonary disease. Therapeutic Archive. 2019;91(8):12-7. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Демко ИВ, Корчагин ЕЕ, Гордеева НВ, и др. Опыт вакцинопрофилактики пневмококковой инфекции у взрослых на примере Красноярского края. Пульмонология. 2017;27(1):21-8. doi:10.18093/0869-0189-2017-27-1-21-28.</mixed-citation><mixed-citation xml:lang="en">Demko IV, Korchagin EE, Gordeeva NV, et al. An experience of vaccination against pneumococcal infection of adults at Krasnoyarsk krai. Pulmonologiya. 2017;27(1):21- 8. (In Russ.) doi:10.18093/0869-0189-2017-27-1-21-28.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Baldo V, Cocchio S, Gallo T, et al. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience. Bueno V, редактор. PLoS ONE. 2016;11(11):e0166637.</mixed-citation><mixed-citation xml:lang="en">Baldo V, Cocchio S, Gallo T, et al. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience. Bueno V, редактор. PLoS ONE. 2016;11(11):e0166637.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">McLaughlin JM, Jiang Q, Isturiz RE, et al. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design. Clinical Infectious Diseases. 2018;67(10): 1498-506.</mixed-citation><mixed-citation xml:lang="en">McLaughlin JM, Jiang Q, Isturiz RE, et al. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design. Clinical Infectious Diseases. 2018;67(10): 1498-506.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults. N Engl J Med. 2015;372(12):1114-25.</mixed-citation><mixed-citation xml:lang="en">Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults. N Engl J Med. 2015;372(12):1114-25.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатова Г.Л., Авдеев С.Н., Антонов В.Н. и др. Вакцинопрофилактика против пневмококковой инфекции, как инструмент снижения смертности у пациентов ХОБЛ и ИБС. Бюллетень физиологии и патологии дыхания. 2024;(94):8-19. doi:10.36604/1998-5029-2024-94-8-19. EDN: LLBJJZ.</mixed-citation><mixed-citation xml:lang="en">Ignatova GL, Avdeev SN, Antonov VN, et al. Vaccination against pneumococcal infection as a tool to reduce mortality in patients with COPD and IHD. Bulletin Physiology and Pathology of Respiration. 2024;(94):8-19. (In Russ.) doi:10.36604/1998-5029-2024-94-8-19. EDN: LLBJJZ.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Рудакова А.В., Брико Н.И., Лобзин Ю.В. и др. Фармако-экономическая эффективность вакцинации пожилых граждан против пневмококковой инфекции в Российской Федерации. Профилактическая медицина. 2021;24(12):41-8.</mixed-citation><mixed-citation xml:lang="en">Rudakova AV, Briko NI, Lobzin YuV, et al. Pharmacoeconomic effectiveness of vaccination of elderly citizens against pneumococcal infection in the Russian Federation. Preventive medicine. 2021;24(12):41-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Рудакова А.В., Брико Н.И., Лобзин Ю.В. и др. Фармакоэ-кономическая эффективность вакцинации против пневмококковой инфекции пациентов с хронической сердечной недостаточностью. Кардиология. 2023;63(5):19-26.</mixed-citation><mixed-citation xml:lang="en">Rudakova AV, Briko NI, Lobzin YuV, et al. Pharmacoeconomic effectiveness of vaccination against pneumococcal infection in patients with chronic heart failure. Kardiolodija. 2023;63(5):19-26. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Рудакова А.В., Брико Н.И., Лобзин Ю.В. и др. Фармако-экономическая эффективность вакцинации против пневмококковой инфекции пациентов с сахарным диабетом. Эпидемиология и вакцинопрофилактика. 2022;21(5):78-88.</mixed-citation><mixed-citation xml:lang="en">Rudakova AV, Briko NI, Lobzin YuV, et al. Pharmacoeconomic effectiveness of vaccination against pneumococcal infection in patients with diabetes mellitus. Epidemiology and vaccine prevention. 2022;21(5):78-88. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines. WHO Technical Report Series. 2013. 978 p.</mixed-citation><mixed-citation xml:lang="en">Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines. WHO Technical Report Series. 2013. 978 p.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Брико Н.И. Оценка качества и эффективности иммунопрофилактики. Лечащий врач. 2012;(10):57.</mixed-citation><mixed-citation xml:lang="en">Brico NI. Assessment of the quality and effectiveness of immunoprophylaxis. The attending physician. 2012;(10):57. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Bruce MG, Bruden D, Hurlburt D, et al. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. J Infect Dis. 2016;214(1):16-22.</mixed-citation><mixed-citation xml:lang="en">Bruce MG, Bruden D, Hurlburt D, et al. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. J Infect Dis. 2016;214(1):16-22.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Masseria C, Krishnarajah G.The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010. BMC Infect Dis. 2015;15(1):534.</mixed-citation><mixed-citation xml:lang="en">Masseria C, Krishnarajah G.The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010. BMC Infect Dis. 2015;15(1):534.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Bellini WJ, Rota JS, Lowe LE, et al. Subacute Sclerosing Panencephalitis: More Cases of This Fatal Disease Are Prevented by Measles Immunization than Was Previously Recognized. J INFECT DIS. 2005;192(10):1686-93.</mixed-citation><mixed-citation xml:lang="en">Bellini WJ, Rota JS, Lowe LE, et al. Subacute Sclerosing Panencephalitis: More Cases of This Fatal Disease Are Prevented by Measles Immunization than Was Previously Recognized. J INFECT DIS. 2005;192(10):1686-93.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Hardie DR, Albertyn C, Heckmann JM, Smuts HE. Molecular characterisation of virus in the brains of patients with measles inclusion body encephalitis (MIBE). Virol J. 2013;10(1):283.</mixed-citation><mixed-citation xml:lang="en">Hardie DR, Albertyn C, Heckmann JM, Smuts HE. Molecular characterisation of virus in the brains of patients with measles inclusion body encephalitis (MIBE). Virol J. 2013;10(1):283.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Ivancic-Jelecki J, Baricevic M, Šantak M, et al. The first genetic characterization of a D4 measles virus strain derived from a patient with subacute sclerosing panencephalitis. Infection, Genetics and Evolution. 2013;17:71-8.</mixed-citation><mixed-citation xml:lang="en">Ivancic-Jelecki J, Baricevic M, Šantak M, et al. The first genetic characterization of a D4 measles virus strain derived from a patient with subacute sclerosing panencephalitis. Infection, Genetics and Evolution. 2013;17:71-8.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang DP, Ide YH, Nagano-Fujii M, et al. Single-point mutations of the M protein of a measles virus variant obtained from a patient with subacute sclerosing panencephalitis critically affect solubility and subcellular localization of the M protein and cell-free virus production. Microbes and Infection. 2009;11(4):467-75.</mixed-citation><mixed-citation xml:lang="en">Jiang DP, Ide YH, Nagano-Fujii M, et al. Single-point mutations of the M protein of a measles virus variant obtained from a patient with subacute sclerosing panencephalitis critically affect solubility and subcellular localization of the M protein and cell-free virus production. Microbes and Infection. 2009;11(4):467-75.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Hotta H, Nihei K, Abe Y, et al. Full-Length Sequence Analysis of Subacute Sclerosing Panencephalitis (SSPE) Virus, a Mutant of Measles Virus, Isolated from Brain Tissues of a Patient Shortly after Onset of SSPE. Microbiology and Immunology. 2006;50(7): 525-34.</mixed-citation><mixed-citation xml:lang="en">Hotta H, Nihei K, Abe Y, et al. Full-Length Sequence Analysis of Subacute Sclerosing Panencephalitis (SSPE) Virus, a Mutant of Measles Virus, Isolated from Brain Tissues of a Patient Shortly after Onset of SSPE. Microbiology and Immunology. 2006;50(7): 525-34.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Miki K, Komase K, Mgone CS, et al. Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea. Journal of Medical Virology. 2002;68(1):105-12.</mixed-citation><mixed-citation xml:lang="en">Miki K, Komase K, Mgone CS, et al. Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea. Journal of Medical Virology. 2002;68(1):105-12.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Woelk CH, Pybus OG, Jin L, et al. Increased positive selection pressure in persistent (SSPE) versus acute measles virus infections. Journal of General Virology. 2002; 83(6):1419-30.</mixed-citation><mixed-citation xml:lang="en">Woelk CH, Pybus OG, Jin L, et al. Increased positive selection pressure in persistent (SSPE) versus acute measles virus infections. Journal of General Virology. 2002; 83(6):1419-30.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2024 году: Государственный доклад. М., 2025. 424 с. ISBN: 978-5-7508-2350-5.</mixed-citation><mixed-citation xml:lang="en">Federal Service for Supervision of Consumer Rights Protection and Human Welfare. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2024: State Report. M., 2025. 424 p. (In Russ.) ISBN: 978-5-7508-2350-5.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Lo NC, Hotez PJ. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017;171(9):887.</mixed-citation><mixed-citation xml:lang="en">Lo NC, Hotez PJ. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017;171(9):887.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Шмитько А.Д., Бочарова И.И. и др. Уровень IgG-антител к вирусу кори в пуповинной крови новорожденных с учетом возраста матерей. Эпидемиология и инфекционные болезни. 2014;19(3):30-4.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Shmitko AD, Bocharova II, et al. The level of IgG antibodies to measles virus in the umbilical cord blood of newborns, taking into account the age of mothers. Epidemiology and infectious diseases. 2014;19(3):30-4. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Филатов Н.Н., Журавлев П.И. и др. Возрастные особенности иммунитета к вирусу кори у работников крупного больничного комплекса мегаполиса. Пульмонология. 2018;28(6):701-7.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Filatov NN, Zhuravlev PI, et al. Age-related features of immunity to the measles virus in employees of a large hospital complex in a megalopolis. Pulmonology. 2018;28(6):701-7. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Филатов Н.Н., Журавлев П.И. и др. Уровень коллективного иммунитета к вирусу кори у сотрудников отдельной больницы в рамках государственной программы элиминации кори. Инфекция и иммунитет. 2020;10(1):129-36.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Filatov NN, Zhuravlev PI, et al. The level of collective immunity to the measles virus among employees of a separate hospital within the framework of the state measles elimination program. Infection and immunity. 2020;10(1):129-36. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Соловьева И.Л., Костинов М.П., Кусельман А.И. и др. Особенности вакцинации детей с измененным преморбидным фоном против гепатита В, кори, эпидемического паротита. Ульяновск: УлГУ, 2006. 296 с.</mixed-citation><mixed-citation xml:lang="en">Solovyova, I.L., Kostinov, M.P., Kuselman AI. et al. Features of vaccination of children with an altered premorbid background against hepatitis B, measles, and mumps. Ulyanovsk: UlSU, 2006. 296 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Полищук В.Б., Рыжов А.А., Костинов М.П. и др. Состояние противокоревого иммунитета у пациентов листа ожидания трансплантации легких. Журнал микробиологии, эпидемиологии и иммунобиологии. 93(4):55-60.</mixed-citation><mixed-citation xml:lang="en">Polishchuk WB, Ryzhov AA, Kostinov MP, et al. The state of anti-acne immunity in patients on the lung transplant waiting list. Journal of Microbiology, Epidemiology and Immunobiology. 93(4):55-60. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Viral Infections of Humans: Epidemiology and Control. Kaslow RA, Stanberry LR, Le Duc JW (eds.), Boston, MA: Springer US; 2014. XVI, 1215 p. ISBN: 978-1-4899-7447-1. doi:10.1007/978-1-4899-7448-8.</mixed-citation><mixed-citation xml:lang="en">Viral Infections of Humans: Epidemiology and Control. Kaslow RA, Stanberry LR, Le Duc JW (eds.), Boston, MA: Springer US; 2014. XVI, 1215 p. ISBN: 978-1-4899-7447-1. doi:10.1007/978-1-4899-7448-8.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Бабиченко И.В., Ибрагимова О.М. Клинические рекомендации (протокол лечения) оказания медицинской помощи детям больным эпидемическим паротитом. М.: ФГБУ НИИДИ ФМБА России, 2015. 27 с.</mixed-citation><mixed-citation xml:lang="en">Babichenko IV, Ibragimova OM. Clinical recommendations (treatment protocol) for providing medical care to children with mumps. Moscow: FSBI NIIDI FMBA of Russia, 2015. 27 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Ющук Н.Д., Венгеров Ю.В. Инфекционные болезни: национальное руководство. 2-е изд. М.: ГЭОТАРМедиа, 2018. 1104 с.</mixed-citation><mixed-citation xml:lang="en">Yushchuk ND, Vengerov SE. Infectious diseases: national guidelines. 2nd ed. Moscow: GEOTAR-Media, 2018. 1104 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. Основы вакцинопрофилактики у детей с хронической патологией. М.: Медицина для всех, 2002. 320 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP. Fundamentals of vaccine prevention in children with chronic pathology. Moscow: Medicine for all, 2002. 320 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Юминова Н.В. Современное состояние вакцинопрофилактики эпидемического паротита в России. Эпидемиология и вакцинопрофилактика. 2002;(2):21-5.</mixed-citation><mixed-citation xml:lang="en">Yuminova NV. The current state of mumps vaccine prevention in Russia. Epidemiology and vaccine prevention. 2002;(2):21-5. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов А.А., Костинов А.М., Ковтун О.П. и др. Стратегии контроля ветряной оспы в России. Итоги международного совещания экспертного совета по вопросам профилактики ветряной оспы (W.A.V.E.). Вопросы со временной педиатрии. 2010;9(3):5-12.</mixed-citation><mixed-citation xml:lang="en">Baranov AA, Kostinov AM, Kovtun OP, et al. Strategies for the control of chickenpox in Russia. Results of the international meeting of the Expert Council on the prevention of chickenpox (W.A.V.E.). Issues from the field of pediatrics. 2010;9(3):5- 12. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Королева И.С., Королева М.А., Чурилова Н.С. и др. Менингококковая инфекция в современных реалиях. Эпидемиология и инфекционные болезни Актуальные вопросы. 2023;13(2):34-9.</mixed-citation><mixed-citation xml:lang="en">Koroleva IS, Koroleva MA, Churilova NS, et al. Meningococcal infection in modern realities. Epidemiology and infectious diseases are topical issues. 2023;13(2):34-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Давыденко М.А., Чурилова Н.С., Королева И.С. Эпидемиологические проявления гнойного бактериального менингита в Российской Федерации. Эпидемиология и вакцинопрофилактика. 2024;23(5): 33-41.</mixed-citation><mixed-citation xml:lang="en">Davydenko MA, Churilova NS, Koroleva IS. Epidemiological manifestations of purulent bacterial meningitis in the Russian Federation. Epidemiology and vaccine prevention. 2024;23(5):33-41. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Фридман И.В., Харит С.М. Профилактика менингококковой инфекции. Медицинский Совет. 2017;(4):16-8.</mixed-citation><mixed-citation xml:lang="en">Friedman YVES, Harith SM. Prevention of meningococcal infection. Medical advice. 2017;(4):16-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Kim YR, Hyun H, Kim EJ, et al. Effectiveness of quadrivalent meningococcal conjugate vaccine against meningococcal carriage and genotype character changes: A secondary analysis of prospective cohort study in Korean military trainees. International Journal of Infectious Diseases. 2024;146:107150.</mixed-citation><mixed-citation xml:lang="en">Kim YR, Hyun H, Kim EJ, et al. Effectiveness of quadrivalent meningococcal conjugate vaccine against meningococcal carriage and genotype character changes: A secondary analysis of prospective cohort study in Korean military trainees. International Journal of Infectious Diseases. 2024;146:107150.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Forcier M, Musacchio N. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention: Overview of HPV for the dermatologist. Dermatologic Therapy. 2010;23(5):458-76.</mixed-citation><mixed-citation xml:lang="en">Forcier M, Musacchio N. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention: Overview of HPV for the dermatologist. Dermatologic Therapy. 2010;23(5):458-76.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Brown DR, Shew ML, Qadadri B, et al. A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women. J INFECT DIS. 2005;191(2):182-92.</mixed-citation><mixed-citation xml:lang="en">Brown DR, Shew ML, Qadadri B, et al. A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women. J INFECT DIS. 2005;191(2):182-92.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24:S42-51.</mixed-citation><mixed-citation xml:lang="en">Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24:S42-51.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Cutts F. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85(09):719-26.</mixed-citation><mixed-citation xml:lang="en">Cutts F. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85(09):719-26.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health. 2020;8(2):e191-203.</mixed-citation><mixed-citation xml:lang="en">Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health. 2020;8(2):e191-203.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Pandhi D, Sonthalia S. Human papilloma virus vaccines: Current scenario. Indian J Sex Transm Dis. 2011;32(2):75.</mixed-citation><mixed-citation xml:lang="en">Pandhi D, Sonthalia S. Human papilloma virus vaccines: Current scenario. Indian J Sex Transm Dis. 2011;32(2):75.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Murillo R, Ordóñez-Reyes C. Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs. International Journal of Gynecological Cancer. 2019;29(8):1317-26.</mixed-citation><mixed-citation xml:lang="en">Murillo R, Ordóñez-Reyes C. Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs. International Journal of Gynecological Cancer. 2019;29(8):1317-26.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Подымова С.Д., Азов А.Г. Вирусные гепатиты у пожилых пациентов. Особенности эпидемиологии, клинической картины, профилактики и лечения. Вирусные гепатиты: достижения и перспективы. 2001;(1):3-4.</mixed-citation><mixed-citation xml:lang="en">Podymova DM, Azov AG. Viral hepatitis in elderly patients. Features of epidemiology, clinical picture, prevention and treatment. Viral hepatitis: achievements and prospects. 2001;(1):3-4. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Шумилов В.И., Шевцов В.А., Лобастов С.П. Опыт изучения антигенной активности инактивированных вакцин против гепатита А. Военно-медицинский журнал. 2001;(12):52.</mixed-citation><mixed-citation xml:lang="en">Shumilov VI, Shevtsov VA, Lobastov SP. Experience in studying the antigenic activity of inactivated hepatitis A vaccines. Military Medical Journal. 2001;(12):52. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Dagan R. Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers. JAMA. 2005;294(2):202.</mixed-citation><mixed-citation xml:lang="en">Dagan R. Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers. JAMA. 2005;294(2):202.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Шевцов В.А., Волгин А.Р. Эффективность и безопасность вакцин для профилактики гепатита А. Иммунология. 2015;36(4):227-30.</mixed-citation><mixed-citation xml:lang="en">Shevtsov VA, Volgin AR. Efficacy and safety of vaccines for the prevention of hepatitis A.Immunology. 2015;36(4):227-30. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Мовсесянц А.А., Олефир Ю.В. Современные проблемы вакцинопрофилактики бешенства. БИОпрепараты. Профилактика, диагностика, лечение. 2019;19(1):10-6.</mixed-citation><mixed-citation xml:lang="en">Movsesyants AA, Olefir SE. Modern problems of rabies vaccination prevention. Biological products. Prevention, diagnosis, and treatment. 2019;19(1):10-6. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Hampson K, Coudeville L, Lembo T, et al. Estimating the Global Burden of Endemic Canine Rabies. Carvalho MS, редактор. PLoS Negl Trop Dis. 2015;9(4):e0003709.</mixed-citation><mixed-citation xml:lang="en">Hampson K, Coudeville L, Lembo T, et al. Estimating the Global Burden of Endemic Canine Rabies. Carvalho MS, редактор. PLoS Negl Trop Dis. 2015;9(4):e0003709.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Лобзин Ю.В., Волжанин В.М., Коваленко А.Н. Брюшной тиф: современное состояние проблемы. Клиническая микробиология и антимикробная химиотерапия. 2005;7(1):47-67.</mixed-citation><mixed-citation xml:lang="en">Lobzin YuV, Volzhanin VM, Kovalenko AN. Typhoid fever: the current state of the problem. Clinical microbiology and antimicrobial chemotherapy. 2005;7(1):47-67. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Stoner MC, Forsythe R, Mills AS, et al. Intestinal perforation secondary to Salmonella typhi: case report and review of the literature. Am Surg. 2000;66(2):219-22.</mixed-citation><mixed-citation xml:lang="en">Stoner MC, Forsythe R, Mills AS, et al. Intestinal perforation secondary to Salmonella typhi: case report and review of the literature. Am Surg. 2000;66(2):219-22.</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Lin FY, Vo AH, Phan VB, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg. 2000;62(5):644-8.</mixed-citation><mixed-citation xml:lang="en">Lin FY, Vo AH, Phan VB, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg. 2000;62(5):644-8.</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet. 1999;354(9180):734-7.</mixed-citation><mixed-citation xml:lang="en">Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet. 1999;354(9180):734-7.</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Ivanoff B. Typhoid fever: global situation and WHO recommendations. Southeast Asian J Trop Med Public Health. 1995;26(Suppl 2):1-6.</mixed-citation><mixed-citation xml:lang="en">Ivanoff B. Typhoid fever: global situation and WHO recommendations. Southeast Asian J Trop Med Public Health. 1995;26(Suppl 2):1-6.</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Цинзерлинг В.А., Коваленко А.Н., Байков В.В. Анализ летальных исходов брюшного тифа. Архив патологии. 2007; (1):3640.</mixed-citation><mixed-citation xml:lang="en">Tsinserling VA, Kovalenko AN, Baykov VV. Analysis of lethal outcomes of typhoid fever. Pathology archive. 2007;(1):3640. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Engels EA, Lau J. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. 2000;(2):CD001261. doi: 10.1002/14651858.CD001261. Update in: Cochrane Database Syst Rev. 2007;(3):CD001261. doi:10.1002/14651858.CD001261.pub2.</mixed-citation><mixed-citation xml:lang="en">Engels EA, Lau J. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. 2000;(2):CD001261. doi: 10.1002/14651858.CD001261. Update in: Cochrane Database Syst Rev. 2007;(3):CD001261. doi:10.1002/14651858.CD001261.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Pegues D, Ohl M, Miller S. Salmonella species, including Salmonella Typhi. In: Mandell G.L., Bennett J.E., Dolin R., editors. Principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone, 2004. 2636-2654 с.</mixed-citation><mixed-citation xml:lang="en">Pegues D, Ohl M, Miller S. Salmonella species, including Salmonella Typhi. In: Mandell G.L., Bennett J.E., Dolin R., editors. Principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone, 2004. 2636-2654 с.</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Parry CM, Hien TT, Dougan G, et al. Typhoid Fever. N Engl J Med. 2002;347(22):1770-82.</mixed-citation><mixed-citation xml:lang="en">Parry CM, Hien TT, Dougan G, et al. Typhoid Fever. N Engl J Med. 2002;347(22):1770-82.</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine. 1996;14(5):435-8.</mixed-citation><mixed-citation xml:lang="en">Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine. 1996;14(5):435-8.</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). The Lancet. 2017;389(10068):505-18.</mixed-citation><mixed-citation xml:lang="en">Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). The Lancet. 2017;389(10068):505-18.</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Gsell PS, Camacho A, Kucharski AJ, et al. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report. The Lancet Infectious Diseases. 2017;17(12):1276-84.</mixed-citation><mixed-citation xml:lang="en">Gsell PS, Camacho A, Kucharski AJ, et al. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report. The Lancet Infectious Diseases. 2017;17(12):1276-84.</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Вачаев Б.Ф., Яговкин Э.А., Ананьина Ю.В. и др. Перспективы применения и совершенствования лептоспирозной вакцины для людей. Эпидемиология и вакцинопрофилактика. 2012;65(4):68-72.</mixed-citation><mixed-citation xml:lang="en">Vachaev BF, Yagovkin EA, Ananyina YuV, et al. Prospects of application and improvement of leptospirosis vaccine for humans. Epidemiology and vaccine prevention. 2012;65(4):68-72. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Haake DA, Levett PN. Leptospirosis in Humans. In: Adler B. (eds) Leptospira and Leptospirosis. Current Topics in Microbiology and Immunology. Berlin.Heidelberg.: Springer, 2015. 387 p.</mixed-citation><mixed-citation xml:lang="en">Haake DA, Levett PN. Leptospirosis in Humans. In: Adler B. (eds) Leptospira and Leptospirosis. Current Topics in Microbiology and Immunology. Berlin.Heidelberg.: Springer, 2015. 387 p.</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Costa F, Hagan JE, Calcagno J, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. Small PLC, редактор. PLoS Negl Trop Dis. 2015;9(9):e0003898.</mixed-citation><mixed-citation xml:lang="en">Costa F, Hagan JE, Calcagno J, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. Small PLC, редактор. PLoS Negl Trop Dis. 2015;9(9):e0003898.</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Лонгвин Ф.В., Кондратенко Ф.В., Водяницкая С.Ю. Сибирская язва в мире, странах СНГ и Российской Федерации (обзор литературы). Медицинский вестник Юга России. 2017;(3):17-22.</mixed-citation><mixed-citation xml:lang="en">Longwin FW, Kondratenko FW, Vodyanitskaya SY. Anthrax in the world, CIS countries and the Russian Federation (literature review). Medical Bulletin of the South of Russia. 2017;(3):17-22. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Еременко Е.И., Рязанова А.Г., Буравцева Н.П. Современная ситуация по сибирской язве в России и мире. Основные тенденции и особенности. Проблемы особо опасных инфекций. 2017;(1):65-71.</mixed-citation><mixed-citation xml:lang="en">Yeremenko YEI, Ryazanova AG, Buravtseva NP. The current situation of anthrax in Russia and the world. Main trends and features. Problems of particularly dangerous infections. 2017;(1):65-71. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru">Микшис Н.И., Кутырев В.В. Современное состояние проблемы разработки вакцин для специфической</mixed-citation><mixed-citation xml:lang="en">Mikshis NI, Kutyrev V. The current state of the problem of developing vaccines for specific plague prevention. Problems of particularly dangerous infections. 2019;(1):50-64. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Здравоохранение в России. Москва: Стат.сб./Росстат., 2019. 170 с.</mixed-citation><mixed-citation xml:lang="en">Healthcare in Russia. Moscow: Stat.sat./Rosstat., 2019. 170 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru">Саяпина Л.В., Соловьев Е.А., Горяев А.А., Бондарев В.П. Изучение иммунобиологических свойств вакцинного штамма Francisella tularensis 15 НИИЭГ в условиях длительного хранения. Проблемы особо опасных инфекций. 2015;(2):87-91.</mixed-citation><mixed-citation xml:lang="en">Sayapina LV, Solovyov EA, Goryaev AA, Bondarev VP. To study the immunobiological properties of the Francisella tularensis 15 NIIEG vaccine strain under long-term storage conditions. Problems of particularly dangerous infections. 2015;(2):87-91. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Говорунов И.Г. Эпидобстановка по туляремии на территории Российской Федерации в 2017-2019 гг. Международная научная конференция SCVRT2019 "Ситуационные центры и информационно-аналитические системы класса 4i для задач мониторинга и безопасности": SCVRT2019 Труды Международной научной конференции, Пущино, 13 ноября 2019 года. Пущино: Научно-исследовательский центр физико-технической информатики, 2019. cc. 84-89. EDN: IWBGXS.</mixed-citation><mixed-citation xml:lang="en">Govorunov IG. The tularemia epidemic in the Russian Federation in 2017-2019. International Scientific Conference SCVRT2019 "Situational centers and information and analytical systems of class 4i for monitoring and security tasks": SCVRT2019 Proceedings of the International Scientific Conference, Pushchino, November 13, 2019. Pushchino: Scientific Research Center for Physical and Technical Informatics, 2019. cc. 84-89. (In Russ.) EDN: IWBGXS.</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru">Саяпина Л.В., Бондарев В.П., Олефир Ю.В. Современное состояние вакцинопрофилактики особо опасных инфекций. Биотехнология, иммунология. 2016;(2):107-10.</mixed-citation><mixed-citation xml:lang="en">Sayapina LV, Bondarev VP, Olefir SE. The current state of vaccination prevention of particularly dangerous infections. Biotechnology, immunology. 2016;(2):107-10. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit123"><label>123</label><citation-alternatives><mixed-citation xml:lang="ru">Ryan ET, Dhar U, Khan WA, et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2000;63(1):12-20.</mixed-citation><mixed-citation xml:lang="en">Ryan ET, Dhar U, Khan WA, et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2000;63(1):12-20.</mixed-citation></citation-alternatives></ref><ref id="cit124"><label>124</label><citation-alternatives><mixed-citation xml:lang="ru">Ali M, Nelson AR, Lopez AL, Sack DA. Updated Global Burden of Cholera in Endemic Countries. Remais JV, редактор. PLoS Negl Trop Dis. 2015;9(6):e0003832.</mixed-citation><mixed-citation xml:lang="en">Ali M, Nelson AR, Lopez AL, Sack DA. Updated Global Burden of Cholera in Endemic Countries. Remais JV, редактор. PLoS Negl Trop Dis. 2015;9(6):e0003832.</mixed-citation></citation-alternatives></ref><ref id="cit125"><label>125</label><citation-alternatives><mixed-citation xml:lang="ru">Кутырев В.В., Девдариани З.Л., Саяпина Л.В. Современное состояние научных исследований в области вакцинопрофилактики особо опасных бактериальных инфекций. Проблемы особо опасных инфекций. 2006;92(2):18-24.</mixed-citation><mixed-citation xml:lang="en">Kutyrev VV, Devdariani ZL, Sayapina LV. The current state of scientific research in the field of vaccine prevention of particularly dangerous bacterial infections. Problems of particularly dangerous infections. 2006;92(2):18-24. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit126"><label>126</label><citation-alternatives><mixed-citation xml:lang="ru">Щуковская Т.Н., Саяпина Л.В., Кутырев В.В. Вакцинопрофилактика холеры: современное состояние вопроса. Эпидемиология и вакцинопрофилактика. 2009; 45(2):62-7.</mixed-citation><mixed-citation xml:lang="en">Shchukovskaya TN, Sayapina LV, Kutyrev BB. Cholera vaccine prevention: the current state of the issue. Epidemiology and vaccine prevention. 2009;45(2):62-7. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit127"><label>127</label><citation-alternatives><mixed-citation xml:lang="ru">Попова А.Ю., Кутырев В.В., Балахонов С.В. др. Координация мероприятий противочумных учреждений Роспотребнадзора по оздоровлению Горно-Алтайского высокогорного природного очага чумы в 2016 г. Проблемы особо опасных инфекций. 2016;(4):5-10.</mixed-citation><mixed-citation xml:lang="en">Popova AY, Kutyrev BB, Balakhonov SV, et al. Coordination of anti-plague institutions of Rospotrebnadzor for the rehabilitation of the Gorno-Altaisk highland natural plague outbreak in 2016. Problems of particularly dangerous infections. 2016;(4):5- 10. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit128"><label>128</label><citation-alternatives><mixed-citation xml:lang="ru">Попов Н.В., Матросов А.Н., Князева Т.В. и др. Эпизоотическая активность природных очагов чумы Российской Федерации в 2016 г., прогноз на 2017 г. Проблемы особо опасных инфекций. 2017;(1):5-12.</mixed-citation><mixed-citation xml:lang="en">Popov NV, Matrosov AN, Knyazeva TV, et al. Epizootic activity of natural plague foci of the Russian Federation in 2016, forecast for 2017 Problems of particularly dangerous infections. 2017;(1):5-12. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit129"><label>129</label><citation-alternatives><mixed-citation xml:lang="ru">Доброхотова Ю.Э., Ганковская Л.В., Бахарева И.В. и др. Роль иммунных механизмов в патогенезе невынашивания беременности. Акушерство и гинекология. 2016;(7):5-10.</mixed-citation><mixed-citation xml:lang="en">Dobrokhotova YUE, Gankovskaya LV, Bakhareva IV, et al. The role of immune mechanisms in the pathogenesis of miscarriage. Obstetrics and gynecology. 2016;(7):5- 10. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit130"><label>130</label><citation-alternatives><mixed-citation xml:lang="ru">Steinborn A, Schmitt E, Kisielewicz A, et al. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clinical and Experimental Immunology. 2011;167(1):84-98.</mixed-citation><mixed-citation xml:lang="en">Steinborn A, Schmitt E, Kisielewicz A, et al. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clinical and Experimental Immunology. 2011;167(1):84-98.</mixed-citation></citation-alternatives></ref><ref id="cit131"><label>131</label><citation-alternatives><mixed-citation xml:lang="ru">Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. REPRODUCTION. 2011;141(6):715-24.</mixed-citation><mixed-citation xml:lang="en">Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. REPRODUCTION. 2011;141(6):715-24.</mixed-citation></citation-alternatives></ref><ref id="cit132"><label>132</label><citation-alternatives><mixed-citation xml:lang="ru">Севостьянова О.Ю., Теплова С.Н., Радзинский В.Е. Иммунный гомеостаз в динамике неосложненной беременности. Вестник РУДН Медицина Акушерство и гинекология. 2005;32(4):39-42.</mixed-citation><mixed-citation xml:lang="en">Sevostyanova OY, Teplova SN, Radzinsky VE. Immune homeostasis in the dynamics of uncomplicated pregnancy. Bulletin of the RUDN University of Medicine, Obstetrics and Gynecology. 2005;32(4):39-42. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit133"><label>133</label><citation-alternatives><mixed-citation xml:lang="ru">Ребров Б.А., Реброва О.А., Комаров Е.Б. Симпозиум "Пневмонии у беременных". Новости медицины и фармации. 2011;18:387.</mixed-citation><mixed-citation xml:lang="en">Rebrov B.A., Rebrova O.A., Komarov E.B. Symposium "Pneumonia in pregnant women". Medical and pharmacy news. 2011;18:387. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit134"><label>134</label><citation-alternatives><mixed-citation xml:lang="ru">Тарбаева Д.А., Костинов М.П., Загородняя Э.Д. и др. Акушерские и перинатальные исходы беременности, осложненной острой респираторной инфекцией во втором триместре гестации. Акушерство и гинекология. 2012;(2): 67-71.</mixed-citation><mixed-citation xml:lang="en">Tarbayeva DA, Kostinov MP, Zagorodnaya ED, et al. Obstetric and perinatal outcomes of pregnancy complicated by acute respiratory infection in the second trimester of gestation. Obstetrics and gynecology. 2012;(2):67-71. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit135"><label>135</label><citation-alternatives><mixed-citation xml:lang="ru">Тарбаева Д.А., Костинов М.П., Иозефсон С.А., Загородняя Э.Д. Клиническое течение и исходы гриппа А (H1N1) 2009 у беременных. Журнал микробиологии, эпидемиологии и иммунологии. 2011;(4):71-6.</mixed-citation><mixed-citation xml:lang="en">Tarbaeva DA, Kostinov MP, Iozefson SA, Zagorodnaya ED. Clinical course and outcomes of influenza A (H1N1) 2009 in pregnant women. Journal of Microbiology, Epidemiology and Immunology. 2011;(4):71-6. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit136"><label>136</label><citation-alternatives><mixed-citation xml:lang="ru">Кузьмин В.Н. Проблема вируса гриппа H1N1 и особенности заболевания у женщин во время беременности. Лечащий врач. 2010;(1):66-8.</mixed-citation><mixed-citation xml:lang="en">Kuzmin VN. The problem of the H1N1 influenza virus and the features of the disease in women during pregnancy. The attending physician. 2010;(1):66-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit137"><label>137</label><citation-alternatives><mixed-citation xml:lang="ru">Siston AM. Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States. JAMA. 2010;303(15):1517.</mixed-citation><mixed-citation xml:lang="en">Siston AM. Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States. JAMA. 2010;303(15):1517.</mixed-citation></citation-alternatives></ref><ref id="cit138"><label>138</label><citation-alternatives><mixed-citation xml:lang="ru">Белокриницкая Т.Е., Тарбаева Д.А., Трубицына А.Ю. и др. Особенности течения свиного гриппа у погибших беременных и в случаях, едва не завершившихся летальным исходом. Лечащий врач. 2013;(3):31-6.</mixed-citation><mixed-citation xml:lang="en">Belokrinitskaya TE, Tarbaeva DA, Trubitsyna AYu, et al. Features of the course of swine flu in dead pregnant women and in cases that almost ended in death. The attending physician. 2013;(3):31-6. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit139"><label>139</label><citation-alternatives><mixed-citation xml:lang="ru">Ortiz JR, Englund JA, Neuzil KM. Influenza vaccine for pregnant women in resourceconstrained countries: A review of the evidence to inform policy decisions. Vaccine. 2011;29(27):4439-52.</mixed-citation><mixed-citation xml:lang="en">Ortiz JR, Englund JA, Neuzil KM. Influenza vaccine for pregnant women in resourceconstrained countries: A review of the evidence to inform policy decisions. Vaccine. 2011;29(27):4439-52.</mixed-citation></citation-alternatives></ref><ref id="cit140"><label>140</label><citation-alternatives><mixed-citation xml:lang="ru">The ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;340(mar18 3):c1279-c1279.</mixed-citation><mixed-citation xml:lang="en">The ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;340(mar18 3):c1279-c1279.</mixed-citation></citation-alternatives></ref><ref id="cit141"><label>141</label><citation-alternatives><mixed-citation xml:lang="ru">Pebody RG, McLean E, Zhao H, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill. 2010;15(20):19571.</mixed-citation><mixed-citation xml:lang="en">Pebody RG, McLean E, Zhao H, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill. 2010;15(20):19571.</mixed-citation></citation-alternatives></ref><ref id="cit142"><label>142</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Черданцев А.П. Клиническая и иммунологическая безопасность инактивированной иммуноадъювантной субъединичной вакцины против гриппа для беременных. Акушерство и гинекология. 2016;(2):64-9.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Cherdantsev AP. Clinical and immunological safety of inactivated immunoadjuvant subunit influenza vaccine for pregnant women. Obstetrics and gynecology. 2016;(2):64-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit143"><label>143</label><citation-alternatives><mixed-citation xml:lang="ru">Шмитько А.Д., Новикова С.В., Бочарова И.И. и др. Механизмы и факторы, влияющие на трансплацентарную передачу антител класса IgG в системе мать-плацента-плод. Российский вестник акушера-гинеколога. 2014;14(6):27-31.</mixed-citation><mixed-citation xml:lang="en">Shmitko AD, Novikova SV, Bocharova II, et al. Mechanisms and factors influencing the transplacental transmission of IgG class antibodies in the mother-placenta-fetus system. Russian Bulletin of the obstetrician-gynecologist. 2014;14(6):27-31. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit144"><label>144</label><citation-alternatives><mixed-citation xml:lang="ru">Бочарова И.И., Костинов М.П., Новикова С.В. и др. Трансплацентарные антитела к вирусу кори у новорожденных при различном течении беременности у их матерей. Российский вестник акушера-гинеколога. 2014;14(2):14-8.</mixed-citation><mixed-citation xml:lang="en">Bocharova II, Kostinov MP, Novikova SV, et al. Transplacental antibodies to measles virus in newborns with different pregnancy course in their mothers. Russian Bulletin of the obstetrician-gynecologist. 2014;14(2):14-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit145"><label>145</label><citation-alternatives><mixed-citation xml:lang="ru">American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Immunization during pregnancy. Obstet Gynecol. 2003;101(1):207-12. doi:10.1016/s0029-7844(02)02738-2.</mixed-citation><mixed-citation xml:lang="en">American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Immunization during pregnancy. Obstet Gynecol. 2003;101(1):207-12. doi:10.1016/s0029-7844(02)02738-2.</mixed-citation></citation-alternatives></ref><ref id="cit146"><label>146</label><citation-alternatives><mixed-citation xml:lang="ru">Kostinov MP, Cherdantsev AP, Kuselman AI, et al. Prospective randomized openlabel comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants. Human Vaccines &amp; Immunotherapeutics. 2018;14(12):2971-8.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Cherdantsev AP, Kuselman AI, et al. Prospective randomized openlabel comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants. Human Vaccines &amp; Immunotherapeutics. 2018;14(12):2971-8.</mixed-citation></citation-alternatives></ref><ref id="cit147"><label>147</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев А.П., Костинов М.П., Кусельман А.И. и др. Иммунитет к вирусу гриппа у новорожденных после вакцинации женщин во время беременности субъединичными иммуноадъювантными и безадъювантными препаратами. Педиатрия Журнал им Г.Н. Сперанского. 2018;97(1):100-5.</mixed-citation><mixed-citation xml:lang="en">Cherdantsev AP, Kostinov MP, Kuselman AI, et al. Immunity to influenza virus in newborns after vaccination of women during pregnancy with subunit immunoadjuvant and non-adjuvant drugs. G.N. Speransky Pediatrics journal. 2018;97(1):100- 5. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit148"><label>148</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев А.П., Костинов М.П., Кусельман А.И. и др. Анализ антеи постнатального развития детей на фоне вакцинации беременных против гриппа. Российский вестник перинатологии и педиатрии. 2013;58(2):30-4.</mixed-citation><mixed-citation xml:lang="en">Cherdantsev AP, Kostinov MP, Kuselman AI, et al. Analysis of the ante- and postnatal development of children against the background of vaccination of pregnant women against influenza. Russian Bulletin of Perinatology and Pediatrics. 2013;58(2):30-4. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit149"><label>149</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Черданцев А.П. Состояние здоровья грудных детей, рожденных от вакцинированных против гриппа беременных. Педиатрия. 2016;95(1):67-71.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Cherdantsev AP. The state of health of infants born to pregnant women vaccinated against influenza. Pediatrics. 2016;95(1):67-71. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit150"><label>150</label><citation-alternatives><mixed-citation xml:lang="ru">Kostinov MP, Cherdantsev AP, Akhmatova NK, et al. Immunogenicity and safety of subunit influenza vaccines in pregnant women. ERJ Open Res. 2018;4(2):00060-2017.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Cherdantsev AP, Akhmatova NK, et al. Immunogenicity and safety of subunit influenza vaccines in pregnant women. ERJ Open Res. 2018;4(2):00060-2017.</mixed-citation></citation-alternatives></ref><ref id="cit151"><label>151</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Пахомов Д.В., Магаршак О.О., Сухинин М.В. Вакцинопрофилактика пневмококковой инфекции как одной из причин осложнений и летальности при гриппе. Вопросы современной педиатрии. 2009;8(6):131-4.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Pakhomov DV, Magarshak OO, Sukhinin MV. Vaccination of pneumococcal infection as one of the causes of complications and mortality in influenza. Issues of modern pediatrics. 2009;8(6):131-4. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit152"><label>152</label><citation-alternatives><mixed-citation xml:lang="ru">Makris MC, Polyzos KA, Mavros MN, et al. Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnancy: A Systematic Review. Drug Safety. 2012;35(1):1-14.</mixed-citation><mixed-citation xml:lang="en">Makris MC, Polyzos KA, Mavros MN, et al. Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnancy: A Systematic Review. Drug Safety. 2012;35(1):1-14.</mixed-citation></citation-alternatives></ref><ref id="cit153"><label>153</label><citation-alternatives><mixed-citation xml:lang="ru">Laibl VR, Sheffield JS. Influenza and Pneumonia in Pregnancy. Clinics in Perinatology. 2005;32(3):727-38.</mixed-citation><mixed-citation xml:lang="en">Laibl VR, Sheffield JS. Influenza and Pneumonia in Pregnancy. Clinics in Perinatology. 2005;32(3):727-38.</mixed-citation></citation-alternatives></ref><ref id="cit154"><label>154</label><citation-alternatives><mixed-citation xml:lang="ru">Salam RA, Das JK, Dojo Soeandy C, et al. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. Cochrane Database Syst Rev. 2015;2015(6):CD009982. doi:10.1002/14651858.</mixed-citation><mixed-citation xml:lang="en">Salam RA, Das JK, Dojo Soeandy C, et al. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. Cochrane Database Syst Rev. 2015;2015(6):CD009982. doi:10.1002/14651858.</mixed-citation></citation-alternatives></ref><ref id="cit155"><label>155</label><citation-alternatives><mixed-citation xml:lang="ru">Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67(2):1-44.</mixed-citation><mixed-citation xml:lang="en">Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67(2):1-44.</mixed-citation></citation-alternatives></ref><ref id="cit156"><label>156</label><citation-alternatives><mixed-citation xml:lang="ru">Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. The Lancet. 2014;384(9953):1521-8.</mixed-citation><mixed-citation xml:lang="en">Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. The Lancet. 2014;384(9953):1521-8.</mixed-citation></citation-alternatives></ref><ref id="cit157"><label>157</label><citation-alternatives><mixed-citation xml:lang="ru">Dabrera G, Amirthalingam G, Andrews N, et al. A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013. Clinical Infectious Diseases. 2015;60(3):333-7.</mixed-citation><mixed-citation xml:lang="en">Dabrera G, Amirthalingam G, Andrews N, et al. A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013. Clinical Infectious Diseases. 2015;60(3):333-7.</mixed-citation></citation-alternatives></ref><ref id="cit158"><label>158</label><citation-alternatives><mixed-citation xml:lang="ru">Baxter R, Bartlett J, Fireman B, et al. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis. Pediatrics. 2017;139(5):e20164091.</mixed-citation><mixed-citation xml:lang="en">Baxter R, Bartlett J, Fireman B, et al. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis. Pediatrics. 2017;139(5):e20164091.</mixed-citation></citation-alternatives></ref><ref id="cit159"><label>159</label><citation-alternatives><mixed-citation xml:lang="ru">McMillan M, Clarke M, Parrella A, et al. Safety of Tetanus, Diphtheria, and Pertussis Vaccination During Pregnancy: A Systematic Review. Obstetrics &amp; Gynecology. 2017; 129(3):560-73.</mixed-citation><mixed-citation xml:lang="en">McMillan M, Clarke M, Parrella A, et al. Safety of Tetanus, Diphtheria, and Pertussis Vaccination During Pregnancy: A Systematic Review. Obstetrics &amp; Gynecology. 2017; 129(3):560-73.</mixed-citation></citation-alternatives></ref><ref id="cit160"><label>160</label><citation-alternatives><mixed-citation xml:lang="ru">Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Obstetrics &amp; Gynecology. 2017;130(3):e153-7.</mixed-citation><mixed-citation xml:lang="en">Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Obstetrics &amp; Gynecology. 2017;130(3):e153-7.</mixed-citation></citation-alternatives></ref><ref id="cit161"><label>161</label><citation-alternatives><mixed-citation xml:lang="ru">Пруцкова Е.В., Черданцев А.П., Андреева Н.П. Вакцины и вакцинация против коклюша детей и взрослых. Инфекционные болезни: новости, мнения, обучение. 2018;14(2):71-7.</mixed-citation><mixed-citation xml:lang="en">Prutskova EV, Cherdantsev AP, Andreeva NP. Vaccines and vaccination against whooping cough in children and adults. Infectious diseases: news, opinions, education. 2018;14(2):71-7. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit162"><label>162</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев А.П., Костинов, М.П., Шмитько А.Д., Черданцева А.А. Вакцинация беременных против управляемых инфекций респираторного тракта. Журнал инфектологии. 2020;12(2):30-7.</mixed-citation><mixed-citation xml:lang="en">Cherdantsev AP, Kostinov, MP, Shmitko AD, Cherdantseva AA. Vaccination of pregnant women against controlled respiratory tract infections. Journal of Infectology. 2020;12(2):30-7. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit163"><label>163</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев А.П., Пруцкова Е.В., Костинов М.П. Новые возможности вакцинопрофилактики коклюша. Детские инфекции. 2020;19(2(71)):58-63.</mixed-citation><mixed-citation xml:lang="en">Cherdantsev AP, Prutskova EV, Kostinov MP. New possibilities of pertussis vaccine prophylaxis. Childhood infections. 2020;19(2(71)):58-63. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit164"><label>164</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О.М., Авдеев С.Н., Брико Н.И. и др. Вакцинация в период пандемии СOVID-19. Методические рекомендации. Москва: РОПНИЗ, ООО "Силицея-Полиграф"; 2022. 96 с.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Avdeev SN, Briko NI, et al. Vaccination during the COVID-19 pandemic. Methodological recommendations. Moscow: ROPNIZ, LLC "Silicea-Polygraph"; 2022. 96 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit165"><label>165</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Квасова М.А., Тарасова А.А. и др. Влияние COVID-19 на исход беременности и оценка вакцинопрофилактики SARS-Cov-2 у беременных и кормящих женщин. Педиатрия Журнал им Г.Н. Сперанского. 2022;101(1): 128-34.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Kvasova MA, Tarasova AA, et al. The impact of COVID-19 on pregnancy outcome and evaluation of SARS-Cov-2 vaccine prophylaxis in pregnant and lactating women. G.N. Speransky Pediatrics journal. 2022;101(1):128-34. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit166"><label>166</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Пруцкова Е.В., Черданцев А.П. и др. Уровень общего IgE и противококлюшных антител у ревакцинированных подростков в зависимости от развития местных и системных реакций. Медицинский вестник МВД. 2024;131(4):88-91.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Prutskova EV, Cherdantsev AP, et al. The level of total IgE and pertussis antibodies in revaccinated adolescents depends on the development of local and systemic reactions. Medical Bulletin of the Ministry of Internal Affairs. 2024;131(4):88- 91. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit167"><label>167</label><citation-alternatives><mixed-citation xml:lang="ru">Clark LR, Johnson DR. Safety and Clinical Benefits of Adacel® and Adacel®- Polio Vaccination in Pregnancy: A Structured Literature Review. Infect Dis Ther. 2023;12(8):1955-2003.</mixed-citation><mixed-citation xml:lang="en">Clark LR, Johnson DR. Safety and Clinical Benefits of Adacel® and Adacel®- Polio Vaccination in Pregnancy: A Structured Literature Review. Infect Dis Ther. 2023;12(8):1955-2003.</mixed-citation></citation-alternatives></ref><ref id="cit168"><label>168</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Адамян Л.В., Черданцева А.П., Озерецкого Н.А. Вакцинация и экстренная иммунопрофилактика инфекционных заболеваний у беременных и кормящих женщин. Москва: Группа МДВ; 2022. 98 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Adamyan LV, Cherdantseva AP, Ozeretsky NA. Vaccination and emergency immunoprophylaxis of infectious diseases in pregnant and lactating women. Moscow: MDV Group; 2022. 98 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit169"><label>169</label><citation-alternatives><mixed-citation xml:lang="ru">Зароченцева Н.В., Баранов И.И., Костинов М.П., Башанкаева Ю.Н. Иммунизация женщины в разные возрастные периоды. ДокторРу. 20(8):70-8.</mixed-citation><mixed-citation xml:lang="en">Zarochentseva NV, Baranov II, Kostinov MP, Bashankaeva Yu N. Immunization of women in different age periods. Doctor.ru. 20(8):70-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit170"><label>170</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Черданцев А.П., Озерецковский Н.А., Никитюк Н.Ф. Иммунопрофилактика инфекционных болезней у женщин в период беременности и грудного вскармливания. Инфекционные болезни: новости, мнения, обучение. 2023;12:73-9.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Cherdantsev AP, Ozeretskovsky NA, Nikityuk SF. Immunoprophylaxis of infectious diseases in women during pregnancy and breastfeeding. Infectious diseases: news, opinions, education. 2023;12:73-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit171"><label>171</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Черданцев А.П. Специфическая профилактика управляемых респираторных инфекций у беременных женщин. Респираторная медицина: руководство в 5 т. Под ред. А.Г. Чучалина, 3-е изд., доп. и перераб. Москва: ПульмоМедиа; 2024. 537 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Cherdantsev AP. Specific prevention of controlled respiratory infections in pregnant women. Respiratory medicine: a 5-volume manual. Edited by A.G. Chuchalin, 3rd ed., supplement and revision. Moscow: Pulmomedia; 2024. 537 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit172"><label>172</label><citation-alternatives><mixed-citation xml:lang="ru">Азаров И.И., Бутаков С.С., Шпунтов А.А. Обеспечение санитарно-эпидемиологического благополучия в Вооруженных Силах Российской Федерации в 2017 году. Здоровье населения и среда обитания. 2018;1(298):15-9.</mixed-citation><mixed-citation xml:lang="en">Azarov II, Butakov SS, Shpuntov AA. Ensuring sanitary and epidemiological welfare in the Armed Forces of the Russian Federation in 2017. Public health and habitat. 2018;1(298):15-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit173"><label>173</label><citation-alternatives><mixed-citation xml:lang="ru">Шубин И.В. Актуальность вакцинопрофилактики пневмококковой инфекции в организованных коллективах военнослужащих. Вестник современной клинической медицины. 2017;10(1):36-42.</mixed-citation><mixed-citation xml:lang="en">Shubin IV. The relevance of vaccinoprophylaxis of pneumococcal infection in organized groups of military personnel. Bulletin of modern Clinical Medicine. 2017;10(1):36-42. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit174"><label>174</label><citation-alternatives><mixed-citation xml:lang="ru">Жданов К.В., Захаренко С.М., Иванов К.С. и др. Проблемы вакцинопрофилактики менингококковой инфекции в Вооруженных Силах. Военномедицинский журнал. 2021;342(6):36-42.</mixed-citation><mixed-citation xml:lang="en">Zhdanov KV, Zakharenko SM, Ivanov KS,et al. Problems of meningococcal infection vaccination in the Armed Forces. Military Medical Journal. 2021;342(6):36-42. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit175"><label>175</label><citation-alternatives><mixed-citation xml:lang="ru">Millar BC, Moore PJA, Moore JE. Meningococcal disease: has the battle been won? J R Army Med Corps. 2017;163(4):235-41.</mixed-citation><mixed-citation xml:lang="en">Millar BC, Moore PJA, Moore JE. Meningococcal disease: has the battle been won? J R Army Med Corps. 2017;163(4):235-41.</mixed-citation></citation-alternatives></ref><ref id="cit176"><label>176</label><citation-alternatives><mixed-citation xml:lang="ru">Белевитин А.Б., Акимкин В.Г., Мосягин В.Д. и др. Организационно-эпидемиологические аспекты профилактики внебольничной пневмонии в воинских коллективах. Военно-медицинский журнал. 2009;330(9):56-63.</mixed-citation><mixed-citation xml:lang="en">Belevitin AB, Akimkin VG, Mosyagin VD, et al. Organizational and epidemiological aspects of community-acquired pneumonia prevention in military groups. Military Medical Journal. 2009;330(9):56-63. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit177"><label>177</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Татевосов В.Р., Протасов А.Д. и др. Вакцинация против Staphylococcus aureus и некоторых представителей семейства Еnterobacteriaceae в комплексном лечении внебольничной пневмонии легкого течения у военнослужащих нового пополнения. Медицинский вестник МВД. 2021;115(6):23-9.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Tatevosov BP, Protasov AD, et al. Vaccination against Staphylococcus aureus and some representatives of the Enterobacteriaceae family in the complex treatment of community-acquired mild pneumonia in newly recruited military personnel. Medical Bulletin of the Ministry of Internal Affairs. 2021;115(6):23-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit178"><label>178</label><citation-alternatives><mixed-citation xml:lang="ru">Татевосов В.Р., Шубин И.В., Костинов М.П., Чучалин А.Г. Оценка результатов вакцинотерапии в комплексном лечении внебольничной пневмонии у лиц молодого возраста в организованных коллективах. Медицинский вестник МВД. 2013;67(6):60-3.</mixed-citation><mixed-citation xml:lang="en">Tatevosov BP, Shubin IV, Kostinov MP, Chuchalin AG. Evaluation of the results of vaccine therapy in the complex treatment of community-acquired pneumonia in young people in organized groups. Medical Bulletin of the Ministry of Internal Affairs. 2013;67(6):60-3. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit179"><label>179</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Зверев В.В., Свитич О.А., Мухачев И.С. Вакцинация лиц, подлежащих призыву на военную службу. Эпидемиология и вакцинопрофилактика. 2023;5(22):58-62.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Zverev BB, Svitich OA, Mukhachev IS. Vaccination of persons subject to conscription. Epidemiology and vaccine prevention. 2023;5(22):58-62. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit180"><label>180</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Зверев В.В., Свитич О.А. Вакцинопрофилактика лиц, подлежащих призыву и поступающих по контракту на военную службу. Руководство для врачей. Под ред. Москва: Группа МДВ, 2024. 56 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Zverev BB, Svitich OA. Vaccination of persons subject to conscription and entering the military service contract. A guide for doctors. Edited by Moscow: MDV Group, 2024. 56 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit181"><label>181</label><citation-alternatives><mixed-citation xml:lang="ru">Пруцкова Е.В., Черданцев А.П., Костинов М.П. и др. Клиническое течение поствакцинального периода у детей, реваккцинированных разными типами вакцин против коклюша. Педиатрия. Журнал им. Г.Н. Сперанского. 2020;99(1):117-20.</mixed-citation><mixed-citation xml:lang="en">Prutskova EV, Cherdantsev AP, Kostinov MP, et al. The clinical course of the postvaccination period in children who were vaccinated with different types of pertussis vaccines. G.N. Speransky Pediatrics journal. 2020;99(1):117-20. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit182"><label>182</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Пруцкова Е.В., Черданцев А.П. и др. Безопасность применения коклюшных вакцин у подростков. Журнал инфектологии. 12(4):29-36.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Prutskova EV, Cherdantsev AP, et al. Safety of pertussis vaccines in adolescents. Journal of Infectology. 12(4):29-36. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit183"><label>183</label><citation-alternatives><mixed-citation xml:lang="ru">Пруцкова Е.В., Черданцев А.П., Костинов М.П. Иммунологические аспекты дополнительной ревакцинации подростков против коклюша, дифтерии и столбняка. Российский вестник перинатологии и педиатрии. 2023;68(4):77-81.</mixed-citation><mixed-citation xml:lang="en">Prutskova EV, Cherdantsev AP, Kostinov MP. Immunological aspects of additional revaccination of adolescents against whooping cough, diphtheria and tetanus. Russian Bulletin of Perinatology and Pediatrics. 2023;68(4):77-81. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit184"><label>184</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Симонова Е.Г., Филатов Н.Н. Эпидемиология и вакцинопрофилактика гриппа в условиях COVID-19. Учебное пособие для дополнительного профессионального образования врачей. Москва: ООО Издательская группа Гэотар-Медиа, 2021. 112 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP, Simonova EG, Filatov NN. Epidemiology and vaccination of influenza in the context of COVID-19. A training manual for additional professional education of doctors. Moscow: Geotar-Media Publishing Group, LLC, 2021. 112 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit185"><label>185</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. Вакцинопрофилактика COVID-19 у пациентов с коморбидными заболеваниями. Руководство для врачей. Под ред. Москва: Группа МДВ; 2022. 176 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP. Vaccine prevention of COVID-19 in patients with comorbid diseases. A guide for doctors. Edited by Moscow: MDV Group; 2022. 176 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit186"><label>186</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов Р.С., Авдеев С.Н., Брико Н.И. и др. Вакцинопрофилактика пневмококковых инфекций у взрослых. Резолюция совета экспертов (Москва, 16 декабря 2017 г.). Клиническая микробиология и антимикробная химиотерапия. 2017;20(1):5-8.</mixed-citation><mixed-citation xml:lang="en">Kozlov RS, Avdeev SN, Briko NI, et al. Vaccination of pneumococcal infections in adults. Resolution of the Council of Experts (Moscow, December 16, 2017). Clinical microbiology and antimicrobial chemotherapy. 2017;20(1):5-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit187"><label>187</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеев С.Н., Дехнич А.В., Зайцев А.А. и др. Внебольничная пневмония: федеральные клинические рекомендации по диагностике и лечению. Пульмонология. 2022;(3):295-355.</mixed-citation><mixed-citation xml:lang="en">Avdeev SN, Dehnich AB, Zaitsev AA, et al. Community-acquired pneumonia: federal clinical guidelines for diagnosis and treatment. Pulmonology. 2022;(3):295-355. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit188"><label>188</label><citation-alternatives><mixed-citation xml:lang="ru">Овчинников Ю.В., Зайцев А.А., Синопальников А.И. Диагностика, лечение и вакцинопрофилактика внебольничной пневмонии у военнослужащих. Методические указания по лечению внебольничной пневмонии у военнослужащих. Москва: ГВКГ им. Н.Н. Бурденко, 2015. 61 с.</mixed-citation><mixed-citation xml:lang="en">Ovchinnikov SW, Zaitsev AA, Sinopalnikov AI. Diagnosis, treatment and vaccination of community-acquired pneumonia in military personnel. Guidelines for the treatment of community-acquired pneumonia in military personnel. Moscow: N.N. Burdenko State Pedagogical University, 2015. 61 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit189"><label>189</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцев А.А., Акимкин В.Г., Брико Н.И. и др. Эпидемиология и вакцинопрофилактика пневмококковых инфекций у военнослужащих. Военно-медицинский журнал. 2019;340(1):39-45.</mixed-citation><mixed-citation xml:lang="en">Zaitsev AA, Akimkin VG, Briko NI, and others. Epidemiology and vaccine prevention of pneumococcal infections in military personnel. Military Medical Journal. 2019; 340(1):39-45. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit190"><label>190</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. От профилактического к терапевтическому эффекту вакцин против пневмококковой и гемофильной типа b инфекций у пациентов с бронхолегочной патологией. Под ред. Москва: Общероссийский фонд "Здоровье человека", 2007. 82 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP. From preventive to therapeutic effect of vaccines against pneumococcal and hemophilic type b infections in patients with bronchopulmonary pathology. Edited by Moscow: All-Russian Foundation for Human Health, 2007. 82 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit191"><label>191</label><citation-alternatives><mixed-citation xml:lang="ru">Leidner AJ, Murthy N, Chesson HW, et al. Cost-effectiveness of adult vaccinations: A systematic review. Vaccine. 2019;37(2):226-34.</mixed-citation><mixed-citation xml:lang="en">Leidner AJ, Murthy N, Chesson HW, et al. Cost-effectiveness of adult vaccinations: A systematic review. Vaccine. 2019;37(2):226-34.</mixed-citation></citation-alternatives></ref><ref id="cit192"><label>192</label><citation-alternatives><mixed-citation xml:lang="ru">Рудакова А.В., Харит С.М., Усков А.Н., Лобзин Ю.В. Анализ эффективности затрат на вакцинацию от гриппа граждан трудоспособного возраста. Медицина экстремальных ситуаций. 2016;56(2):25-36.</mixed-citation><mixed-citation xml:lang="en">Rudakova AV, Harit SM, Uskov AN, Lobzin SW. Analysis of the cost effectiveness of flu vaccination for working-age citizens. Medicine of extreme situations. 2016;56(2):25-36. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit193"><label>193</label><citation-alternatives><mixed-citation xml:lang="ru">Shea KM, Edelsberg J, Weycker D, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014;1(1):ofu024.</mixed-citation><mixed-citation xml:lang="en">Shea KM, Edelsberg J, Weycker D, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014;1(1):ofu024.</mixed-citation></citation-alternatives></ref><ref id="cit194"><label>194</label><citation-alternatives><mixed-citation xml:lang="ru">Рудакова А.В., Брико Н.И., Лобзин Ю.В. и др. Вакцинация взрослых против пневмококковой инфекции в Российской Федерации: социальные и фармакоэкономические аспекты. Журнал инфектологии. 2018;10(3):11-22.</mixed-citation><mixed-citation xml:lang="en">Rudakova AV, Briko NI, Lobzin YuV, and others. Adult vaccination against pneumococcal infection in the Russian Federation: social and pharmacoeconomic aspects. Journal of Infectology. 2018;10(3):11-22. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit195"><label>195</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатова Г.Л., Антонов В.Н. Анализ влияния вакцинации против пневмококковой инфекции на течение коморбидной патологии у пациентов с хронической обструктивной болезнью легких и хронической сердечной недостаточностью. Терапевтический архив. 2018;90(8):53-62.</mixed-citation><mixed-citation xml:lang="en">Ignatova GL, Antonov VN. Analysis of the effect of vaccination against pneumococcal infection on the course of comorbid pathology in patients with chronic obstructive pulmonary disease and chronic heart failure. Therapeutic Archive. 2018;90(8):53-62. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit196"><label>196</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. Вакцинация взрослых: персонифицированный подход. В: Руководство для врачей. Москва: ГЭОТАР-Медиа; 2024. с. 192.</mixed-citation><mixed-citation xml:lang="en">Kostinov MP. Adult vaccination: a personalized approach. Q: A guide for doctors. Moscow: GEOTAR-Media; 2024. p. 192. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
